1. Inicio
  2. Proyectos y Estudios
  3. ESTUDIO DE FASE III, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE IDELALISIB (GS-1101) EN COMBINACIÓN CON BENDAMUSTINA Y RITUXIMAB EN LINFOMAS NO HODGKIN INDOLENTES PREVIAMENTE TRATADOS.

ESTUDIO DE FASE III, ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, PARA EVALUAR LA EFICACIA Y SEGURIDAD DE IDELALISIB (GS-1101) EN COMBINACIÓN CON BENDAMUSTINA Y RITUXIMAB EN LINFOMAS NO HODGKIN INDOLENTES PREVIAMENTE TRATADOS.

Datos básicos

Código:
GS-US-313-0125
Protocolo:
GS-US-313-0125
EUDRACT:
2012-004034-42
NCT:
Centro:
Dotación:
Año de incio:
Año de finalización:
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

GILEAD SCIENCES INC

Resultados del Ensayo Clínico

(18F)FDG-PET-CT in patients with spondylodiscitis: image, clinical and laboratory findings in 10 cases

Bernal, J.; (...); Bello-Arques, P.

Meeting Abstract. 2019


[ 177 Lu]Lu-DOTA-TATE and [ 131 I]MIBG Phenotypic Imaging-Based Therapy in Metastatic/Inoperable Pheochromocytomas and Paragangliomas: Comparative Results in a Single Center.

Prado-Wohlwend, Stefan; (...); Merino-Torres, Juan Francisco

Article. 10.3389/fendo.2022.778322. 2022


[Farewell open letter to SEFH members].

Poveda Andrés JL

Editorial Material. 10.7399/fh.2015.39.6.10128. 2015


[Translated article] Cybersecurity: a priority for pharmacy services in the age of artificial intelligence

Marin, Cayetano M. Hernandez, Monte-Boquet, Emilio, Andres, Jose Luis Poveda

Editorial Material. 10.1016/j.farma.2024.08.009. 2024

  • Open Access.

[Translated article] Good humanisation practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Andrés JLP, Solsona MDE

Article. 10.1016/j.farma.2023.10.004. 2024


[Translated article] New challenges in advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2024.05.001. 2024


[Translated article] Pharmacokinetic-guided switching from standard half-life factor VIII to extended half-life pegylated factor VIII in haemophilia A therapy in clinical practice.

Chovi-Trull, Maria; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.12.007. 2025


[Translated article] Real-world effectiveness and safety of nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma.

Fernandez, Laura Lorente; (...); Andres, Jose Luis Poveda

Article. 10.1016/j.farma.2024.09.006. 2024

  • Open Access.

177Lu-DOTATATE (PRRT) in the treatment of patients with gastroenteropancreatic neuroendocrine tumors (GEPNETs) versus other tumors

Jimenez-Fonseca, P.; (...); Carmona-Bayonas, A.

Meeting Abstract. 2022


177-Lu-DOTATATE in 200 Patients with Neuroendocrine Tumors: Real-World Data from the SEPTRALU Registry

Carmona-Bayonas, A; (...); Jimenez-Fonseca, P

Meeting Abstract. 2020


177-Lu-DOTATATE in 382 patients with somatostatin receptor-positive advanced tumors: Real-world data from the SEPTRALU registry

Casanovas M, Mitjavila; (...); Carmona-Bayonas, A.

Meeting Abstract. 2022


177Lu-DOTATATE in advanced neuroendocrine neoplasms of different locations - Data from 552 cases in the SEPTRALU registry

Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.

Meeting Abstract. 2023


177Lu-DOTATATE in advanced neuroendocrine tumours: real word data from SEPTRALU registry

Mitjavila Casanovas, M.; (...); Carmona-Bayona, A.

Meeting Abstract. 2019


2019 SEFH National Survey: service portfolio, care activities, education and research in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11611. 2021


3D patient-specific spinal cord computational model for SCS management: potential clinical applications.

Solanes C; (...); Saiz J

Article. 10.1088/1741-2552/abe44f. 2021


A Confidence Habitats Methodology in MR Quantitative Diffusion for the Classification of Neuroblastic Tumors.

Cerda Alberich, Leonor; (...); Marti-Bonmati, Luis

Article. 10.3390/cancers12123858. 2020


A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients.

Lozano ML; (...); Vicente V

Article. 10.1016/j.bcmd.2020.102505. 2021


A Gadolinium(III) Complex Based on Pyridoxine Molecule with Single-Ion Magnet and Magnetic Resonance Imaging Properties.

Orts-Arroyo, Marta; (...); Martinez-Lillo, Jose

Article. 10.3390/ijms25042112. 2024


A Gadolinium(III) Complex Based on the Thymine Nucleobase with Properties Suitable for Magnetic Resonance Imaging

Orts-Arroyo, M; (...); Martinez-Lillo, J

Article. 10.3390/ijms22094586. 2021


A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study.

Rios-Tamayo, Rafael; (...); Mateos, Maria Victoria

Article. 10.1080/16078454.2023.2178997. 2023


A method for liver segmentation in perfusion MR images using probabilistic atlases and viscous reconstruction

Dura, E; (...); Marti-Bonmati, L

Article. 10.1007/s10044-017-0666-z. 2018


A multicentre ambispective observational study into the incidence and clinical management of aplastic anaemia in Spain (IMAS study)

Vallejo C; (...); Codesido ML

Article. 10.1007/s00277-023-05602-x. 2024


A multicriteria decision analysis (MCDA) applied to three long-term prophylactic treatments for hereditary angioedema in Spain

Zozaya, Neboa; (...); Hidalgo-Vega, Alvaro

Article. 10.33393/grhta.2022.2333. 2022


A multi-criteria decision analysis on the value of nintedanib for interstitial lung diseases.

Zozaya, Neboa; (...); Verde, Luis

Article. 10.1017/S0266462322000459. 2022


A multiparameter flow cytometry immunophenotypic algorithm for the identification of newly diagnosed symptomatic myeloma with an MGUS-like signature and long-term disease control.

Paiva B; (...); Grupo Español de MM

Article. 10.1038/leu.2013.166. 2013


A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.

de Andrés-Nogales F; (...); Martínez-Olmos J

Article. 10.1007/s41669-020-00201-2. 2020


A MULTI-STAKEHOLDER MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD STUDY.

Casado, MA; (...); Grp MULTIDEX-EMD

Meeting Abstract. 10.1016/j.jval.2018.09.2545. 2018


A new definition and refocus of pharmaceutical care: the Barbate Document

Morillo-Verdugo R; (...); Poveda-Andrés JL

Article. 10.7399/fh.11389. 2020


A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis

Cibeira, MT; (...); Blade, J

Article. 10.1111/bjh.13500. 2015


A practical solution to estimate the sample size required for clinical prediction models generated from observational research on data

Baeza-Delgado, Carlos; (...); Marti-Bonmati, Luis

Article. 10.1186/s41747-022-00276-y. 2022


A randomized phase II study comparing consolidation with a single dose of Y-90 ibritumomab tiuxetan vs. maintenance with rituximab for two years in patients with newly diagnosed follicular lymphoma responding to R-CHOP. Long-term follow-up results

Lopez-Guillermo, Armando; (...); Tomas, Jose Francisco

Article. 10.1080/10428194.2021.1971216. 2021


A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS)

Hajek, R; (...); Ludwig, H

Article. 10.1038/leu.2016.176. 2017


A rare case of diffuse and bilateral pulmonary uptake in 18 F-FDG PET/CT scan.

Olivan-Sasot, P; (...); Bello-Arques, P

Editorial Material. 10.1016/j.remn.2020.11.007. 2021


A rare case of diffuse and bilateral pulmonary uptake in 18F-FDG PET/CT scan.

Olivan-Sasot, P; (...); Bello-Arques, P

Article. 10.1016/j.remnie.2020.11.002. 2021


A simple score to predict early severe infections in patients with newly diagnosed multiple myeloma

Encinas, Cristina; (...); Martinez-Lopez, Joaquin

Article. 10.1038/s41408-022-00652-2. 2022


A Systematic Approach for Using DICOM Structured Reports in Clinical Processes: Focus on Breast Cancer

Medina García R; (...); Almenar Cubells D

Article. 10.1007/s10278-014-9728-6. 2015


A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia

Megías-Vericat JE; (...); Aliño SF

Article. 10.1038/tpj.2015.80. 2016


Accelerating the Diffusion-Weighted Imaging Biomarker in the clinical practice: comparative study

Torro, FB; (...); Bonmati, LM

Proceedings Paper. 10.1016/j.procs.2017.05.108. 2017


Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI

França M; (...); Pessegueiro Miranda H

Article. 10.1007/s00261-017-1048-0. 2017


Acute hemolytic reaction by anti-Wra: Case report and review of the hemovigilance database of a tertiary care hospital.

Solves, Pilar; (...); de la Rubia, Javier

Article. 10.1016/j.transci.2021.103342. 2022


ADAMTS13 RECOVERY IN ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA AFTER CAPLACIZUMAB THERAPY. THE SPANISH REGISTRY.

Mingot-Castellano, Maria Eva; (...); Pascual Izquierdo, Cristina

Article. 10.1182/blood.2023022725. 2024


Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin's lymphoma: report on three cases and literature review

Romero, S; (...); Sanz, J

Review. 10.1177/20406207211038181. 2021


Adherence and adverse events of intraperitoneal chemotherapy in optimally debulked ovarian cancer patients: Real-life study.

Ballesta-López O; (...); Poveda-Andrés JL

Article. 10.1177/1078155220915953. 2020


Adjuvanted recombinant zoster vaccine in adult autologous stem cell transplant recipients: polyfunctional immune responses and lessons for clinical practice

Stadtmauer, Edward A.; (...); ZOE-SCT Study Grp Collaborators

Article. 10.1080/21645515.2021.1953346. 2021


Adoptive transfer of ex-vivo expanded SARS-CoV-2-specific Cytotoxic Lymphocytes: a viable strategy for COVID-19 immunosuppressed patients?

Guerreiro M; (...); Piñana JL

Article. 10.1111/tid.13602. 2021


Aflibercept in exudative age related macular degeneration refractory to ranibizumab.

Ruiz Ramos J; (...); Gallego-Pinazo R

Article. 10.1016/j.oftal.2015.07.018. 2015


Alnuctamab (ALNUC; BMS-986349; CC-93269), a 2+1 B- Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), Administered Subcutaneously (SC) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Updated Results from a Phase 1 First-in-Human Clinical Study

Bar, Noffar; (...); Costa, Luciano

Meeting Abstract. 10.1182/blood-2023-180013. 2023


Alnuctamab (ALNUC; BMS-986349; CC-93269), a B-Cell Maturation Antigen (BCMA) x CD3 T-Cell Engager (TCE), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from a Phase 1 First-in-Human Clinical Study

Wong, Sandy W.; (...); Costa, Luciano J.

Meeting Abstract. 10.1182/blood-2022-159009. 2022


Alternatives of the pelvic sentinel lymph node migration pathway in early ovarian cancer: the simplest the best.

Lago, Victor; (...); Domingo, Santiago

Article. 10.1136/ijgc-2023-004912. 2023


Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma. Impact of disease characteristics, disease status at transplant, and prior number of lines of therapy. Results of retrospective, multicentre Spanish study

De la Rubia, J; (...); Gonzalez, MS

Meeting Abstract. 2019


ALLOGENEIC TRANSPLANTATION OF HEMATOPOIETIC PROGENITORS (T-ALO) IN PATIENTS WITH MULTIPLE MYELOMA (MM). IMPACT OF BIOLOGICAL CHARACTERISTICS TO DIAGNOSIS, TPH DISEASE SITUATION AND TREATMENT LINES. SPANISH MULTICENTRIC RETROSPECTIVE STUDY

Perez, A.; (...); Solano, C.

Meeting Abstract. 2019

  • Open Access.

Amyloid brain-dedicated PET images can diagnose Alzheimer's pathology with Centiloid Scale.

Gandia-Ferrero MT; (...); Martí-Bonmatí L

Article. 10.1016/j.ejmp.2024.103345. 2024


Analisis de las causas de suspension de tratamiento con triple terapia antiviral en pacientes con hepatitis C.

Ruiz Ramos J; (...); Poveda Andrés JL

Abstract of Published Item. 10.7399/fh.2014.38.3.1171. 2014


Analysing criteria for price and reimbursement of orphan drugs in Spain.

Badia, X; (...); Tort, M

Article. 10.7399/fh.11147. 2019


Analysis of chemical contamination by hazardous drugs with BD HD Check(R) system in a tertiary hospital

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/10781552211038518. 2021


Analysis of minimal residual disease in bone marrow by NGF and in peripheral blood by mass spectrometry in newly diagnosed multiple myeloma patients enrolled in the GEM2012MENOS65 clinical trial.

Puig, Noemi; (...); Mateos, Maria-Victoria

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.8010. 2021


Analysis of Peripheral Blood and Bone Marrow Residual Disease Dynamics during Intensive Treatment and Maintenance in Patients with Multiple Myeloma Included in the GEM12MENOS65 and GEM14MAIN Clinical Trials

Puig, Noemi; (...); Victoria Mateos, Maria

Meeting Abstract. 10.1182/blood-2023-184837. 2023


ANALYSIS OF PROGRESSION-FREE SURVIVAL OF AND GLOBAL SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA OLDER THAN 65 YEARS CANDIDATES FOR AUTOLOGOUS PERIPHERAL BLOOD TRANSPLANTATION NON-CANDIDATES

Cejalvo, MJ; (...); De la Rubia, J

Meeting Abstract. 2017

  • Open Access.

ANALYSIS OF RESIDUAL DISEASE IN PERIPHERAL BLOOD BY MEANS OF MASS SPECTROMETRY IN PATIENTS WITH MULTIPLE MYELOMA OF THE GEM 2012 MINUS65. COMPARISON WITH THE IMWG STANDARD RESPONSE AND RESIDUAL DISEASE CRITERIA

Puig, N.; (...); Mateos, M., V

Meeting Abstract. 2021

  • Open Access.

ANALYSIS OF THE PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ELDERLY PATIENTS (65 YEARS OLD) WITH MULTIPLE MYELOMA PATIENTS ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANTATION.

Cejalvo, MJ; (...); De la Rubia J

Meeting Abstract. 2018

  • Open Access.

Anidulafungin-Induced Alopecia

Ruiz-Ramos J; (...); Poveda-Andrés JL

Article. 10.1177/1060028014524534. 2014


Anti-angiogenic drug loaded liposomes: Nanotherapy for early atherosclerotic lesions in mice

Pont I; (...); Albelda MT

Article. 10.1371/journal.pone.0190540. 2018


Antimicrobial stewardship programme implementation in a medical ward

Ruiz, J; (...); Poveda, JL

Article. 2018


Antimicrobial stewardship programme in critical care medicine: A prospective interventional study

Ruiz, J; (...); Catellanos, A

Article. 10.1016/j.medin.2017.07.002. 2018


Artificial intelligence and machine learning in cancer imaging.

Koh DM; (...); Prior F

Article. 10.1038/s43856-022-00199-0. 2022


Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease.

Prats-Climent, Joan; (...); Marti-Bonmati, Luis

Article. 10.1007/s10916-022-01836-w. 2022


Assessing the value of moderate-to-severe atopic dermatitis treatment using multi-criteria decision analysis (MCDA).

Pereyra-Rodríguez JJ; (...); Ortiz de Frutos FJ

Letter. 10.1111/jdv.19432. 2023


Assessment of a well-differentiated pancreatic neuroendocrine tumor with 68 Ga-DOTATOC PET/CT, 68 Ga-DOTATOC PET/MRI and 99m Tc-octreotide SPECT/CT. What does each scan provide?

Prado-Wohlwend, S.; (...); Bello-Arques, P.

Editorial Material. 10.1016/j.remn.2020.05.012. 2021


Assessment of a well-differentiated pancreatic neuroendocrine tumor with 68Ga-DOTATOC PET/CT, 68Ga-DOTATOC PET/MRI and 99mTc-octreotide SPECT/CT. What does each scan provide?

Prado-Wohlwend, S; (...); Bello-Arques, P

Article. 10.1016/j.remnie.2020.08.002. 2021


Assessment of the dicentric chromosome assay as a biodosimetry tool for more personalized medicine in a case of a high risk neuroblastoma I-131-mIBG treatment

Chimeno, JM; (...); Montoro, A

Article. 10.1080/09553002.2019.1549755. 2018


Assessment of the quality of sample labelling for clinical research.

Pérez-Huertas P; (...); Poveda-Andrés JL

Article. 10.7399/fh.2016.40.2.9753. 2016


Assessment of Treatment Response By Ife, Next Generation Flow Cytometry and Mass Spectrometry Coupled with Liquid Chromatography in the GEM2012MENOS65 Clinical Trial

Puig, Noemi; (...); Mateis, Maria-Victoria

Meeting Abstract. 10.1182/blood-2021-151557. 2021


Association of Pelvic Organ Prolapse and Changes in Bone Imaging Biomarkers in Postmenopausal Women with Low Bone Mineral Density

Arguedas, Maria Perez; (...); Marti-Bonmati, Luis

Article. 10.31083/j.ceog5104092. 2024


Association of SNPs with the efficacy and safety of immunosuppressant therapy after heart transplantation

Sánchez-Lázaro I; (...); Aliño SF

Article. 10.2217/pgs.15.39. 2015


Auditory hallucinations in first-episode psychosis: A voxel-based morphometry study

Escarti, MJ; (...); PEPs Grp

Article. 10.1016/j.schres.2019.05.001. 2019


Autoimmune cytopenias after umbilical cord blood transplantation in adults with hematological malignancies: a single-center experience

Sanz J; (...); Sanz GF

Article. 10.1038/bmt.2014.107. 2014


Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis

Casanova, B; (...); Coret, F

Article. 10.1007/s10072-017-2933-6. 2017


Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

Briones J; (...); Grupo Español de Linfomas y Trasplante Autologo de Médula Ósea (GELTAMO)

Letter. 10.3324/haematol.2014.108308. 2014


Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan plus BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

Briones J; (...); GELTAMO

Article. 10.3324/haematol.2013.093450. 2014


Autologous stem cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.

García-Sancho AM; (...); Caballero D

Article. 10.3324/haematol.2021.279426. 2022


Autologous Stem Cell Transplantation for Follicular Lymphoma: Favorable Long-Term Survival Irrespective of Pretransplantation Rituximab Exposure

Jiménez-Ubieto A; (...); Lahuerta JJ

Article. 10.1016/j.bbmt.2017.05.021. 2017


Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment

Jimenez-Ubieto, A; (...); GELTAMO Grp Espanol Linfomas Tr

Article. 10.1002/hon.2553. 2018


Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy.

Jiménez-Ubieto A; (...); GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Stu

Article. 10.1016/j.hemonc.2019.06.001. 2019


Autologous Stem Cell Transplantation may potentially abrogate the negative prognostic effect of early relapse after chemo or inmunochemotherapy in Follicular Lymphoma

Ubieto, AJ; (...); Lahuerta, JJ

Meeting Abstract. 2018


Automated Cervical Spinal Cord Segmentation in Real-World MRI of Multiple Sclerosis Patients by Optimized Hybrid Residual Attention-Aware Convolutional Neural Networks

Bueno, America; (...); Alberich-Bayarri, Angel

Article. 10.1007/s10278-022-00637-4. 2022


Automated Glioblastoma Segmentation Based on a Multiparametric Structured Unsupervised Classification

Juan-Albarracín J; (...); García-Gómez JM

Article. 10.1371/journal.pone.0125143. 2015


Automated prostate multi-regional segmentation in magnetic resonance using fully convolutional neural networks

Jimenez-Pastor, Ana; (...); Alberich-Bayarri, Angel

Article. 10.1007/s00330-023-09410-9. 2023


Automated vertebrae localization and identification by decision forests and image-based refinement on real-world CT data.

Jimenez-Pastor A; (...); Marti-Bonmati L

Article. 10.1007/s11547-019-01079-9. 2020


Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.

Martí-Aguado D; (...); Martí-Bonmatí L

Article. 10.1148/radiol.2021211027. 2022


Automatic individual arterial input functions calculated from PCA outperform manual and population-averaged approaches for the pharmacokinetic modeling of DCE-MR images

Sanz-Requena, R; (...); Ferrer, A

Article. 10.1002/jmri.24805. 2015


Automatic magnetic resonance imaging series labelling for large repositories

Gomis-Maya, Armando; (...); Marti-Bonmati, Luis

Article. 10.1186/s40537-025-01086-w. 2025


AUTONOMOUS TRANSPLANTATION CAN MITIGATE THE ADVERSE PROGNOSIS OF THE EARLY RELAPSE AFTER CHEMO OR IMMUNOCHEMOTHERAPY INDUCTION IN FOLLICULAR LYMPHOMA

Ubieto, AJ; (...); Lahuerta, J. J.

Meeting Abstract. 2017

  • Open Access.

Avatrombopag in immune thrombocytopenia: A real-world study of the Spanish ITP Group (GEPTI).

Pascual-Izquierdo C; (...); Mingot-Castellano ME

Article. 10.1002/ajh.27498. 2024


Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients.

Iglesias Gómez R; (...); Poveda Andrés JL

Article. 10.1136/ejhpharm-2021-002741. 2021


Bayesian pharmacokinetic individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018


Bayesian pharmacokinetic-guided prophylaxis with recombinant factor VIII in severe or moderate haemophilia A

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2018.12.027. 2019


Belantamab Mafodotin in Combination with Vrd for the Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Results from the Phase II, Open Label, Multicenter, GEM-BELA-Vrd Trial

Gonzalez-Calle, Veronica; (...); Mateos, Maria-Victoria

Meeting Abstract. 10.1182/blood-2022-162584. 2022


Belantamab Mafodotin in Combination with VRd for the Treatment of Newly Diagnosed Transplant Eligible Multiple Myeloma Patients: Results from the Phase II, Open Label, Multicenter, GEM-BELA-VRd Trial

Gonzalez-Calle, Veronica; (...); Mateos, Maria-Victoria

Meeting Abstract. https://doi.org/10.1182/blood-2022-162584. 2024


Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma Included in the Compassionate Use or the Expanded Access Program. Experience with a Spanish Cohort

De la Rubia, Javier; (...); Alegre, Adrian

Meeting Abstract. 10.1182/blood-2022-158538. 2022


Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma: Results of the Compassionate Use or the Expanded Access Program in Spain.

de la Rubia, Javier; (...); Alegre, Adrian

Article. 10.3390/cancers15112964. 2023


Bendamustine as part of conditioning of autologous stem cell transplantation in patients with aggressive lymphoma: a phase 2 study from the GELTAMO group

Redondo, AM; (...); GEL-TAMO

Article. 10.1111/bjh.15713. 2019


Bendamustine plus rituximab in untreated chronic lymphocytic leukemia patients. The MDA-CLL-2015-02 study

De La Fuente, A; (...); Baltasar, P

Meeting Abstract. 2017


Best practices and recommendations for drug regimens and plasma exchange for immune thrombotic thrombocytopenic purpura

Gomez-Segui, I, Izquierdo, CP, Comos, JD

Review. 10.1080/17474086.2021.1956898. 2021


Beyond the Briganti nomogram: Individualisation of lymphadenectomy using selective sentinel node biopsy during radical prostatectomy for prostate cancer

Monserrat-Monfort, JJ; (...); Boronat-Tormo, F

Article. 10.1016/j.acuro.2016.06.002. 2017


Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study.

Fernandez Rivera C; (...); Hernandez D

Article. 10.1111/ctr.14550. 2022


Biosimilares: viejas polemicas con nuevos argumentos.

Poveda-Andrés JL, Bosó-Ribelles V

Editorial Material. 10.7399/fh.2015.39.3.8978. 2015


BK Virus-Associated Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation in the Pediatric Population

Perez-Huertas, P; (...); Poveda-Andres, JL

Article. 10.1177/1043454216631952. 2017


Bloodstream Infections in Adult Patients Undergoing Cord Blood Transplantation from Unrelated Donors after Myeloablative Conditioning Regimen

Sanz J; (...); Sanz GF

Article. 10.1016/j.bbmt.2014.12.038. 2015


Bortezomib and thalidomide maintenance after stem cell transplantation for multiple myeloma: a PETHEMA/GEM trial

Rosiñol L; (...); Bladé J

Article. 10.1038/leu.2017.35. 2017


Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplantation in multiple myeloma.

Rosiñol L; (...); Bladé J

Article. 10.1182/blood.2019000241. 2019


Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma

Blanes M; (...); de la Rubia J

Article. 10.3109/10428194.2014.922182. 2015


Brain network functional connectivity changes in patients with anterior knee pain: a resting-state fMRI exploratory study.

Sanchis-Alfonso, Vicente; (...); Marti-Bonmati, Luis

Article. 10.1186/s41747-023-00378-1. 2023


Brain signal intensity changes as biomarkers in amyotrophic lateral sclerosis

Vazquez-Costa, JF; (...); Sevilla, T

Article. 10.1111/ane.12863. 2018


Breakthrough invasive fungal disease in high-risk hematologic malignancies in children: a single-center experience

Garcia-Robles, AA; (...); Fernandez-Navarro, JM

Meeting Abstract. 2017


Bridging gaps between images and data: a systematic update on imaging biobanks.

Gabelloni, Michela; (...); Neri, Emanuele

Article. 10.1007/s00330-021-08431-6. 2022


Buenas practicas para el uso seguro de las bolsas tricamerales de nutricion parenteral.

Sirvent M; (...); Grupo de Nutrición Clínica de la SEFH

Abstract of Published Item. 10.7399/fh.2014.38.5.8085. 2014


BUMEL vs MEL-200 prior autologous transplant for patients with newly diagnosed multiple myeloma previously treated with bortezomib, lenalidomide and dexamethasone: final results of a phase 3 trial

Lahuerta Palacios, Juan Jose; (...); Blade, Joan

Meeting Abstract. 2022


Calidad y Legibilidad de la Hoja de Informacion al Paciente en Estudios con Analisis Farmacogenetico.

Ruiz Ramos J; (...); Poveda Andrés JL

Article. 2015


Caplacizumab Frontline Added to Therapeutic Plasma Exchange and Immunosuppression Prevents Unfavorable Outcomes in Immune-Mediated TTP: An International Real-World Study of the TTP-IWG (The Capla 500 Project)

Coppo, Paul; (...); Scully, Marie

Meeting Abstract. 10.1182/blood-2023-179316. 2023


Caplacizumab Treatment in Elderly Patients with iTTP: Updated Experience from the Spanish TTP Registry

Gomez Segui, Ines; (...); De La Rubia, Javier

Meeting Abstract. 10.1182/blood-2023-180970. 2023


Cardiorespiratory coupling in cetaceans; a physiological strategy to improve gas exchange?

Fahlman A; (...); Blawas A

Article. 10.1242/jeb.226365. 2020


Central Nervous System Involvement in Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders after Allogeneic Hematopoietic Stem Cell Transplantation.

Balaguer-Rosello, Aitana; (...); Sanz, Jaime

Article. 10.1016/j.jtct.2020.12.019. 2021


Circulating Tumor Cells for the Staging of Patients With Newly Diagnosed Transplant-Eligible Multiple Myeloma.

Garces, Juan-Jose; (...); Paiva, Bruno

Article. 10.1200/JCO.21.01365. 2022


Cis-Acting Splicing-Associated Variants Can Redefine the Molecular Signature of Genes Commonly Mutated in Acute Myeloid Leukemia

Morote-Faubel, Mireya; (...); Cervera, Jose

Meeting Abstract. 10.1182/blood-2023-177571. 2023

  • Open Access.

Clinical application of the sentinel lymph node technique in early ovarian cancer: a pilot study

Lago, V; (...); Domingo, S

Article. 10.1136/ijgc-2018-000049. 2019


CLINICAL APPLICATION OF THE SENTINEL LYMPH NODE TECHNIQUE IN EARLY OVARIAN CANCER: PHASE II CLINICAL TRIAL

Lago, V.; (...); Domingo, S.

Meeting Abstract. 10.1136/ijgc-2019-ESGO.944. 2019


Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients

Megias-Vericat, JE; (...); Poveda, JL

Article. 10.1016/j.thromres.2021.07.009. 2021


Clinical Characteristics and Transfusion Management of Patients Diagnosed of Multiple Myeloma Receiving Daratumumab: Experience of a Single Centre

Arnao, M; (...); Sanz, G

Meeting Abstract. 10.1016/j.clml.2019.09.254. 2019


Clinical Characteristics, Treatment Approach and Long-Term Outcomes of 678 Patients with Symptomatic Waldenstrom's Macroglobulinemia: Comprehensive Insights from a Spanish Registry of IgM Gammapathies

Askari, Elham; (...); Garcia-Sanz, Ramon

Meeting Abstract. 10.1182/blood-2023-189581. 2023

  • Open Access.

Clinical evaluation of rituximab treatment for neuromyelitis optica

Fernández-Megía MJ; (...); Poveda-Andrés JL

Article. 10.1016/j.nrl.2014.09.001. 2015


Clinical experience of whole body and tumour dosimetry of 131-I-mIBG treatment for pediatric patients

Espallardo, I. Torres; (...); Prado-Wohlwend, S.

Meeting Abstract. 2023


Clinical experiences with cannabinoids in spasticity management in multiple sclerosis

Lorente Fernández L; (...); Casanova-Estruch B

Article. 10.1016/j.nrl.2013.06.014. 2014


Clinical Impact of Next Generation Flow in Bone Marrow Vs Qip-Mass Spectrometry in Peripheral Blood to Assess Minimal Residual Disease in Newly Diagnosed Multiple Myeloma Patients Receiving Maintenance As Part of the GEM2014MAIN Trial

Puig, Noemi; (...); Mateos, Maria-Victoria

Meeting Abstract. 10.1182/blood-2022-165441. 2022


Clinical pharmacy services: from cost-effectiveness analysis to a productivity indicators model

Nogueras, A; (...); Calleja, MA

Letter. 10.1136/ejhpharm-2019-001905. 2019


Clinical Significance and Transcriptional Profiling of Persistent Minimal Residual Disease (MRD) in Multiple Myeloma (MM) Patients with Standard-Risk (SR) and High-Risk (HR) Cytogenetics

Goicoechea, I; (...); Paiva, B

Meeting Abstract. 10.1182/blood-2018-99-113312. 2018


CMV REACTIVATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT FROM HLA-MATCHED AND HAPLOIDENTICAL DONORS WITH POST-TRANSPLANT CYCLOPHOSPHAMIDE.

Chorão P; (...); Sanz J

Article. 10.1016/j.jtct.2024.01.082. 2024


Collaborative model of home delivery program in haemophilia through an association of patients

Megias-Vericat, JE; (...); Bonanad, S

Meeting Abstract. 2018


ComBat harmonization in different PET imaging scenarios

Gandia-Ferrero, M.; (...); Marti-Bonmati, L.

Meeting Abstract. 2023


Comment on "Outcomes of autologous transplantation for multiple myeloma according to different induction regimens".

de la Rubia J

Article. 10.5581/1516-8484.20140020. 2014


Common seasonal respiratory virus infections in allogeneic stem cell transplant recipients during the SARS-COV-2 pandemic.

De La Puerta R; (...); Piñana JL

Article. 10.1038/s41409-021-01319-5. 2021


Comparative Multicentric Evaluation of Inter-Observer Variability in Manual and Automatic Segmentation of Neuroblastic Tumors in Magnetic Resonance Images

Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis

Article. 10.3390/cancers14153648. 2022


COMPARATIVE STUDY OF THE CHARACTERISTICS OF THE DIAGNOSIS AND RESPONSE TO TREATMENT IN PATIENTS AGED=60 YEARS VS. <60 YEARS WITH ACQUIRED PURPLE THROMBOTIC THROMBOCYTOPENIC. RESULTS OF THE SPANISH REGISTRATION OF PTT (REPTT)

Aracil Eva, Frances; (...); Comos Javier, De la Rubia

Meeting Abstract. 2021

  • Open Access.

Comparison between whole-body F-18-FDG PET/CT and MRI in patients with SDH gene mutation paragangliomas: a preliminary study

Olivan-Sasot, P; (...); Bello-Arques, P

Meeting Abstract. 2018


Comparison of 3D dosimetry methods in hepatic radioembolisation with Y-90 microspheres

Carrasco Vela, N.; (...); Torres-Espallardo, I.

Meeting Abstract. 2021

  • Open Access.

Comparison of patient comfort between iodixanol and iopamidol in contrast-enhanced computed tomography of the abdomen and pelvis: a randomized trial

Weiland, FL; (...); Becker, HC

Article. 10.1177/0284185113505277. 2014


Comparison of pharmacokinetic estimates using generic and specific population pharmacokinetic models of plasma-derived factor VIII/VWF using WAPPS-Hemo

Megias-Vericat, JE; (...); Poveda, JL

Meeting Abstract. 2020


Comparison of protocols with respiratory-gated (4D) motion compensation in PET/CT: open-source package for quantification of phantom image quality.

Martinez-Movilla, Andrea; (...); Carles, Montserrat

Article. 10.1186/s40658-022-00509-4. 2022


COMPARISON OF THREE PANELS OF NGS APPLICATION IN ONCOHEMATOLOGY TO DISCARD SOMATIC AND/OR GERMINAL VARIANTS

Guzman-Gimenez, C.; (...); Such, E.

Meeting Abstract. 2021

  • Open Access.

Comparison of transfusion requirements in adult patients undergoing Haploidentical or single-unit umbilical cord blood stem cell transplantation

Solves, P; (...); Sanz, GF

Article. 10.1111/ejh.13270. 2019


COMPREHENSIVE LONG-TERM FOLLOW-UP OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: A REPORT FROM A SINGLE CENTRE

Sempere, A.; (...); Jarque, I.

Meeting Abstract. 2016

  • Open Access.

CONCURRENT MUTATIONS IN ZRSR2 AND TET2 CAUSE SMD-COMPATIBLE ANOMALIES IN A MOUSE MODEL

Cristian, Garcia-Ruiz; (...); Alejandra, Sanjuan-Pla

Meeting Abstract. 2021

  • Open Access.

Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano JB; (...); Soto-Ortega I

Article. 10.1016/j.farma.2023.01.003. 2023


Consensus recommendations for the improvement of inter- and intra-centre care coordination in the management of hemophilia.

Montoro-Ronsano, Jose Bruno; (...); Soto-Ortega, Inmaculada

Article. 10.1016/j.farma.2023.04.002. 2023


Considerations for artificial intelligence clinical impact in oncologic imaging: an AI4HI position paper

Marti-Bonmati L; (...); Tsakou G

Article. 10.1186/s13244-022-01220-9. 2022


Correlation Between Clinical Characteristics And Effective Washout Time In Patients Treated With High Radioiodine Activities

Guerrero Calatayud, C.; (...); Bello Arques, P.

Meeting Abstract. 2023


Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive aspergillosis among patients with haematological disorders in Germany and Spain

Ostermann, H; (...); Charbonneau, C

Article. 10.1186/2050-6511-15-52. 2014


COST MINIMIZATION ANALYSIS OF RITUXIMAB BIOSIMILAR VERSUS REFERENCE RITUXIMAB IN THE TREATMENT OF FOLLICULAR LYMPHOMA

Gironella, M.; (...); Oyaguez, I

Meeting Abstract. 2019

  • Open Access.

COST-EFFECTIVENESS ANALYSIS OF DIFELIKEFALIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE ASSOCIATED-PRURITUS IN SPAIN

Sanchez-Alvarez, Emilio E.; (...); Hernaez Colque, M.

Meeting Abstract. 2024


Cost-effectiveness analysis of implementing an antimicrobial stewardship program in critical care units

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1080/13696998.2017.1311903. 2017


Cost-effectiveness of Cladribine Tablets and fingolimod in the treatment of relapsing multiple sclerosis with high disease activity in Spain.

Poveda JL; (...); Torres C

Article. 10.1080/14737167.2019.1635014. 2020


COST-EFFECTIVENESS OF CLADRIBINE TABLETS AND FINGOLIMOD IN THE TREATMENT OF REMITTING MULTIPLE SCLEROSIS WITH HIGH DISEASE ACTIVITY IN SPAIN

Trillo, JL; (...); Torres, C

Meeting Abstract. 10.1016/j.jval.2018.09.2029. 2018


Cost-effectiveness of methoxy polyethylene glycolepoetin beta versus conventional epoetin in the treatment of anaemia secondary to chronic kidney disease in clinical practice

Lorente-Fernandez, L; (...); Poveda-Andres, JL

Article. 10.1136/ejhpharm-2013-000426. 2015


COSTS OF THE MANAGEMENT OF HEMOPHILIA A WITH INHIBITORS IN SPAIN

Bonanad, S; (...); Gonzalez-Dominguez, A

Meeting Abstract. 2020


Costs of the management of hemophilia A with inhibitors in Spain

Bonanad, S; (...); Gonzalez-Dominguez, A

Article. 10.33393/grhta.2021.2234. 2021


Cost-utility analysis of idelalisib in combination with rituximab in relapsed or refractory chronic lymphocytic leukaemia

Casado, LF; (...); Castro, A

Article. 10.1111/ejh.13007. 2018


COST-UTILITY OF IDELALISIB IN COMBINATION WITH RITUXIMAB IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

Casado, LF; (...); Castro-Gomez, A

Meeting Abstract. 10.1016/j.jval.2017.08.898. 2017


Critical evaluation of ASO RQ-PCR for minimal residual disease evaluation in multiple myeloma. A comparative analysis with flow cytometry

Puig N; (...); García-Sanz R

Article. 10.1038/leu.2013.217. 2014


Critical review of HCC imaging in the multidisciplinary setting: treatment allocation and evaluation of response

Amorim J; (...); Martí-Bonmatí L

Review. 10.1007/s00261-020-02470-1. 2020


CRITICAL REVIEW OF THE DOUBLE NEGATIVITY IN THE SERUM AND URINE IMMUNOFIXATION (IF) TO ESTABLISH THE CATEGORY OF COMPLETE REMISSION IN MULTIPLE MYELOMA (MM)

Anglada, LL; (...); Lahuerta, J. J.

Meeting Abstract. 2017

  • Open Access.

Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate (R)) and BAY 81-8973 (KovaltryA (R)) in patients with severe or moderate haemophilia A in prophylaxis

Megias-Vericat, JE; (...); Poveda, JL

Letter. 10.1111/hae.13733. 2019


Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Eduardo Megias, Juan; (...); Iorio, Alfonso

Meeting Abstract. 10.1182/blood-2019-127946. 2019


Curative Strategy (GEM- CESAR) for High-Risk Smoldering Myeloma (SMM): Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd

Mateos, Maria-Victoria; (...); San-Miguel, Jesus F.

Meeting Abstract. 10.1182/blood-2021-148423. 2021


Curative Strategy (GEM-CESAR) for High-Risk Smoldering Myeloma (SMM): Post-Hoc Analysis of Sustained Undetectable Measurable Residual Disease (MRD)

Mateos, Maria-Victoria; (...); Paiva, Bruno

Meeting Abstract. 10.1182/blood-2022-159606. 2022


Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.

Mateos, Maria-Victoria; (...); San-Miguel, Jesus F

Article. 10.1200/JCO.23.02771. 2024


Current knowledge on tumour induction by computed tomography should be carefully used

Candela-Juan C; (...); Martí-Bonmatí L

Article. 10.1007/s00330-013-3047-z. 2014


Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective

Hubel, K; (...); Corradini, P

Review. 10.1111/ejh.12362. 2015


CXCR4: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.

Sanchis-Pascual, David; (...); Merino-Torres, Juan Francisco

Article. 10.3390/cancers16101799. 2024


Cybersecurity, a priority for pharmacy services in the age of artificial intelligence.

Hernández Marín CM, Monte-Boquet E, Poveda Andrés JL

Editorial Material. 10.1016/j.farma.2024.08.001. 2024


CYTOGENETIC ANALYSIS IN REAL LIFE IN PATIENTS WITH MULTIPLE MYELOMA NEW DIAGNOSIS Results: FROM THE MULTIPLE MYELOMA STUDY GROUP OF THE VALENCIAN COMMUNITY (GREMI)

Gomez, Beltran Elena; (...); De la Rubia, Comos Javier

Meeting Abstract. 2020

  • Open Access.

Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.

Diaz-Gonzalez, Alvaro; (...); Such, Esperanza

Article. 10.3390/cancers15113039. 2023


Cytokine response as a biomarker for early diagnosis and outcome prediction of stem cell transplant recipients and acute leukemia patients with invasive aspergillosis.

Puerta-Alcalde, Pedro; (...); Garcia-Vidal, Carolina

Article. 10.1093/mmy/myac038. 2022


CHAIMELEON Project: Creation of a Pan-European Repository of Health Imaging Data for the Development of AI-Powered Cancer Management Tools.

Bonmati, Luis Marti; (...); Alberich-Bayarri, Angel

Article. 10.3389/fonc.2022.742701. 2022


Characterization of Bone Microarchitecture Extracted from MR and MDCT. Feature Analysis Validated Against a Synthetic Trabecular Bone Phantom

Ten-Esteve, A; (...); Alberich-Bayarri, A

Proceedings Paper. 10.1007/978-3-319-68195-5_71. 2018


Chronic liver disease-associated severe thrombocytopenia in Spain: Results from a retrospective study using machine learning and natural language processing.

Calleja-Panero, Jose Luis; (...); Gonzalez Calvo, Jose

Article. 10.1016/j.gastrohep.2023.05.010. 2023


CHRONOLOGICAL AGE AS A PROGNOSTIC FACTOR IN PATIENTS WITH MULTIPLE MYELOMA NEW DIAGNOSIS NOT CANDIDATED FOR TRANSPLANTATION

Martinez Elena, Meseguer; (...); Comos Javier, De la Rubia

Meeting Abstract. 2021

  • Open Access.

Chronological age as a prognostic factor in transplant-ineligible patients with newly diagnosed Multiple Myeloma

Garcia Ruiz, Raquel; (...); de la Rubia, Javier

Meeting Abstract. 2021


Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

Moreau, Philippe; (...); Goldschmidt, Hartmut

Letter. 10.1038/s41408-023-00805-x. 2023


Data harmonisation for information fusion in digital healthcare: A state-of-the-art systematic review, meta-analysis and future research directions

Nan, Yang; (...); Yang, Guang

Review. 10.1016/j.inffus.2022.01.001. 2022


Data infrastructures for AI in medical imaging: a report on the experiences of five EU projects

Kondylakis, Haridimos; (...); Lekadir, Karim

Article. 10.1186/s41747-023-00336-x. 2023


Daunorubicin and cytarabine for certain types of poor-prognosis acute myeloid leukemia: a systematic literature review

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.1080/17512433.2019.1573668. 2019


Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (vol 11, 16867, 2021)

Lozano, Maria L.; (...); Vicente, Vicente

Article. 10.1038/s41598-021-95732-x. 2021


Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia.

Lozano ML; (...); Vicente V

Article. 10.1038/s41598-019-53209-y. 2019


Decompression sickness ('the bends') in sea turtles

Garcia-Parraga, D; (...); Fernandez, A

Article. 10.3354/dao02790. 2014


DEEP INTRONIC MUTATIONS IN THE RUNX1 AND FLT3 GENES PRODUCE OPENING SPLICING IN PATIENTS WITH MYELODYSPLASIC SYNDROMES

Mireia, Boluda-Navarro; (...); Jose, Cervera

Meeting Abstract. 2021

  • Open Access.

Deep learning automatic semantic segmentation of glioblastoma multiforme regions on multimodal magnetic resonance images.

Beser-Robles, Maria; (...); Marti-Bonmati, Luis

Article. 10.1007/s11548-024-03205-z. 2024


Defining a set of standardised outcome measures for newly diagnosed patients with multiple myeloma using the Delphi consensus method: the IMPORTA project

Blade, J; (...); Lizan, L

Article. 10.1136/bmjopen-2017-018850. 2018


Definition and Clinical Significance of the MGUS-like Phenotype: A Study in 5,114 Patients (Pts) with Monoclonal Gammopathies

Burgos, Leire; (...); Paiva, Bruno

Meeting Abstract. 10.1182/blood-2021-150092. 2021


Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies.

Burgos, Leire; (...); Paiva, Bruno

Article. 10.1200/JCO.22.01916. 2023


Dental Flat Panel Conebeam CT in the Evaluation of Patients with Inflammatory Sinonasal Disease: Diagnostic Efficacy and Radiation Dose Savings

Leiva-Salinas, C; (...); Ramírez P

Article. 10.3174/ajnr.A4019. 2014


Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials

Lahuerta, JJ; (...); GEM (Grupo Español de Mieloma)

Article. 10.1200/JCO.2016.69.2517. 2017


Depth of Response of Isatuximab (Isa) plus Carfilzomib (K) and Dexamethasone (d) in Relapsed Multiple Myeloma: IKEMA Updated Analysis

Joseph, Mikhael; (...); Meletios, A. Dimopoulos

Article. 2022


Depth of response of isatuximab plus carfilzomib and dexamethasone in relapsed multiple myeloma: IKEMA updated analysis

Hajek, Roman; (...); Dimopoulos, Meletios A.

Meeting Abstract. 2022


DESCRIPTIVE STUDY OF THE RECORD OF THROMBOTIC MICROANGIOPATHY IN A SINGLE CENTRE

Romero Dominguez, S.; (...); Sanz Alonso, M. A.

Meeting Abstract. 2015

  • Open Access.

Design and rationale for a real-world prospective, multicenter registry of myocardial revascularization failure and secondary revascularization: The REVASEC study.

Salinas P; (...); Escaned J

Article. 10.1016/j.carrev.2021.11.015. 2021


Design and validation of a decision support checklist for efficient resource allocation in research projects during proposal preparation.

Penades-Blasco, Ana; (...); Marti-Bonmati, Luis

Article. 10.1016/j.ejrad.2024.111362. 2024


DETERMINATION OF THE CHALLENGES AND OPPORTUNITIES ASSOCIATED WITH PLATELET TRANSFUSION IN THE MANAGEMENT OF PATIENTS WITH SEVERE THROMBOCYTOPENIA ASSOCIATED WITH CHRONIC LIVER DISEASE

Jarque, Ramos, I; (...); Shepherd, Moreno J.

Meeting Abstract. 2020

  • Open Access.

DETERMINING THE EPIDEMIOLOGY, PATIENT FLOW, TREATMENT AND UNMET NEEDS OF PATIENTS WITH CHRONIC LIVER DISEASE-ASSOCIATED SEVERE THROMBOCYTOPENIA UNDERGOING INVASIVE PROCEDURES IN SPAIN

Andrade, R.; (...); Shepherd, J.

Meeting Abstract. 2019


Determining the value contribution of emicizumab (Hemlibra (R)) for the prophylaxis of haemophilia A with inhibitors in Spain by multi-criteria decision analysis

Alvarez-Roman, MT; (...); Badia, X

Article. 10.1177/2284240319880534. 2019


DETERMINING THE VALUE OF EMICIZUMAB FOR THE PROPHYLAXIS OF SEVERE HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS IN SPAIN BY MULTI-CRITERIA DECISION ANALYSIS (MCDA)

Alvarez, E.; (...); Badia, F. J.

Meeting Abstract. 2019


Determining value in the treatment of activated PI3Kdelta syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

Abad, Maria Reyes; (...); Gil, Alicia

Article. 10.33393/grhta.2024.3041. 2024


Determining what represents value in the treatment of prurigo nodularis and its key unmet needs in Spain through Multi-Criteria Decision Analysis

Silvestre, Juan Francisco; (...); Serra-Baldrich, Esther

Article. 10.1002/jvc2.275. 2024


Development and evaluation of two open-source nnU-Net models for automatic segmentation of lung tumors on PET and CT images with and without respiratory motion compensation.

Carles, Montserrat; (...); Gkika, Eleni

Article. 10.1007/s00330-024-10751-2. 2024


Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale

Bonanad S; (...); GAH Group

Article. 10.1016/j.jgo.2015.03.003. 2015


DEVELOPMENT AND VALIDATION OF A MCDA FRAMEWORK FOR EVALUATION AND DECISION-MAKING OF ORPHAN DRUGS IN SPAIN

Poveda, J. L.; (...); Vitoria, I

Meeting Abstract. 2019


Development and validation of an image biomarker to identify metabolic dysfunction associated steatohepatitis: MR-MASH score

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1111/liv.15766. 2024


Development and validation of an MCDA framework for evaluation and decision-making of orphan drugs in Spain

Badia, X; (...); Poved, JL

Article. 10.1080/21678707.2019.1652163. 2019


Development of imaging biomarkers and generation of big data

Alberich-Bayarri, A; (...); Marti-Bonmati, L

Article. 10.1007/s11547-017-0742-x. 2017


Development of severity and mortality prediction models for covid-19 patients at emergency department including the chest x-ray

Calvillo-Batllés P; (...); Martí-Bonmatí L

Article. 10.1016/j.rx.2021.09.011. 2022


Development of severity and mortality prediction models for covid-19 patients at emergency department including the chest x-ray.

Calvillo-Batllés P; (...); Martí-Bonmatí L

Article. 10.1016/j.rxeng.2021.09.004. 2022


Diagnostico y tratamiento del carcinoma hepatocelular. Actualizacion del documento de consenso de la AEEH, SEOM, SERAM, SERVEI y SETH.

Forner A; (...); Bruix J

Article. 10.1016/j.medcli.2016.01.028. 2016


DICOM-MIABIS integration model for biobanks: a use case of the EU PRIMAGE project

Scapicchio C; (...); Neri E

Article. 10.1186/s41747-021-00214-4. 2021


Difference in Regional Brain Volume between Fibromyalgia Patients and Long-Term Meditators

Fayed, Nicolas; (...); Garcia-Campayo, Javier

Article. 2017


Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients

Marti-Aguado, D; (...); Marti-Bonmati, L

Article. 10.1016/j.crad.2020.07.031. 2020


Differences in technical and clinical perspectives on AI validation in cancer imaging: mind the gap!

Chouvarda, Ioanna; (...); Papanikolaou, Nikolaos

Article. 10.1186/s41747-024-00543-0. 2025


Digital Pathology Enables Automated and Quantitative Assessment of Inflammatory Activity in Patients with Chronic Liver Disease.

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.3390/biom11121808. 2021


Digital pathology: accurate technique for quantitative assessment of histological features in metabolic-associated fatty liver disease

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1111/apt.16100. 2021


Do Guidelines Influence Diagnostic and Therapeutic Practice in Immune Thrombocytopenia? Results of a Multicenter Retrospective Study

Luisa Lozano, Maria; (...); Vicente Garcia, Vicente

Meeting Abstract. 10.1182/blood-2019-125557. 2019


Do SPECT CT and sentinel node tecnhique increase the diagnosis of metastasic disease in prostate cancer?

Perez Ardavin, J.; (...); Vera-Donoso, C. D.

Meeting Abstract. 2022


Documenting the de-identification process of clinical and imaging data for AI for health imaging projects

Kondylakis, Haridimos; (...); Tsiknakis, Manolis

Article. 10.1186/s13244-024-01711-x. 2024


Does radiographic location ensure precise anatomic location of the femoral fixation site in medial patellofemoral ligament surgery?

Sanchis-Alfonso, V; (...); Marti-Bonmati, L

Article. 10.1007/s00167-015-3523-x. 2016


Dose banding aplicado a la elaboracion de antineoplasicos: una revision narrativa de la literatura.

Pérez Huertas P; (...); Poveda Andrés JL

Article. 10.7399/fh.2015.39.4.8839. 2015


Drug Interaction Between Oral Cyclosporine Modified and Iron

Domingo-Chiva, E; (...); Poveda-Andres, JL

Article. 10.1177/1060028013514734. 2014


Dynamic contrast-enhanced case-control analysis in 3T MRI of prostate cancer can help to characterize tumor aggressiveness

Sanz-Requena, R; (...); Garcia-Marti, G

Article. 10.1016/j.ejrad.2016.09.022. 2016


Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases

Megias-Vericat, JE; (...); Poveda, JL

Review. 10.1007/s10072-017-2833-9. 2017


EBV-associated post-transplant lymphoproliferative disorder after umbilical cord blood transplantation in adults with hematological diseases

Sanz J; (...); Sanz GF

Article. 10.1038/bmt.2013.190. 2014


Economic evaluation of azoles as primary prophylaxis for the prevention of invasive fungal infections in Spanish patients undergoing allogeneic haematopoietic stem cell transplant

Solano C; (...); Bow EJ

Article. 10.1111/myc.12552. 2017


ECONOMIC IMPACT LINKED TO THE REDUCTION OF EXACERBATIONS WHEN A TREATMENT REGIME WITH INHALED ANTIBIOTICS IS SWITCHED TO AZTREONAM LYSINE IN PATIENTS WITH CYSTIC FIBROSIS AND CHRONIC PULMONARY INFECTION CAUSED BY PSEUDOMONAS AERUGINOSA

Sole A; (...); Casado MA

Meeting Abstract. 10.1016/j.jval.2014.08.1659. 2014


Economic impact of optimising antiretroviral treatment in human immunodeficiency virus-infected adults with suppressed viral load in Spain, by implementing the grade A-1 evidence recommendations of the 2015 GESIDA/National AIDS Plan

Ribera, E; (...); Hernandez-Novoa, B

Article. 10.1016/j.eimc.2016.11.015. 2018


Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome

Cañigral C; (...); Sanz MA

Letter. 10.1007/s00277-013-1970-3. 2014


Editorial: Infectious diseases and hematology: diagnosis and management

Gonzalez-Lopez, Tomas Jose; (...); Di Micco, Pierpaolo

Editorial Material. 10.3389/fmed.2024.1385874. 2024


Efecto de la adición de fortificantes y de módulo de proteínas en la osmolalidad de la leche materna donada.

Torres Martínez E; (...); Vento M

Article. 10.1016/j.anpedi.2020.03.009. 2020


Effect of Caplacizumab in the Recovery of ADAMTS13 Level in Patients with Autoimmune Thrombotic Thrombocytopenic Purpura. Analysis from the Spanish Registry (REPTT)

Eva Mingot, Maria; (...); Del Rio Garma, Julio

Meeting Abstract. 10.1182/blood-2023-182876. 2023


Effect of CD8(+) Cell Content on Umbilical Cord Blood Transplantation in Adults with Hematological Malignancies

Moscardó F; (...); Sanz GF

Article. 10.1016/j.bbmt.2014.06.038. 2014


EFFECT OF CYP3A5 GENOTYPE ON TACROLIMUS DOSE REQUIREMENT, NEPHROTOXICITY AND ACUTE REJECTION IN KIDNEY TRANSPLANTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES

Rojas, L.; (...); Alino, S. F.

Article. 2013


Effect of CYP3A5*3 on kidney transplant recipients treated with tacrolimus: a systematic review and meta-analysis of observational studies

Rojas L; (...); Aliño SF

Article. 10.1038/tpj.2014.38. 2015


EFFECT OF PREGNANCY IN THE CLINICAL COURSE OF PREGNANT WOMEN WITH PTI AND THEIR OFFSPRING. RESULTS OF A SERIES OF SPANISH CASES WITH 263 PREGNANCIES IN PRIMARY PTI

Lopez, TJG; (...); Hermida, G.

Meeting Abstract. 2017

  • Open Access.

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial

Bastidas, A; (...); ZOE-HSCT Study Grp Collaborators

Article. 10.1001/jama.2019.9053. 2019


Effectiveness of Caplacizumab Nanobody in Acquired Thrombotic Thrombocytopenic Purpura Refractory to Conventional Treatment

Palanques-Pastor T; (...); Poveda Andrés JL

Article. 10.1159/000517813. 2021


Effects of 3 Tesla magnetic resonance imaging exposure on the behavior and orientation of homing pigeons Columba livia domestica.

Parraga, Daniel Garcia; (...); Marti-Bonmati, Luis

Article. 10.1371/journal.pone.0241280. 2020


EFFECTS OF POLYMORPHIMS OF CYP3A5 AND ABCB1 GENES ON CHRONIC NEPHROPATHY: COHORT STUDY

Rojas, L.; (...); Alino, S. F.

Article. 2013


Efficacy and clinical and neuroimaging biomarkers of response of two intensive and spaced treatment protocols of theta burst magnetic stimulation in treatment resistant depression

Canada, Y.; (...); Sierra, P.

Meeting Abstract. 10.1192/j.eurpsy.2023.1269. 2023

  • Open Access.

Efficacy and Safety of 177Lu-DOTATATE in Lung Neuroendocrine Tumors: A multicenter study

Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.

Meeting Abstract. 2023


Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study.

Mitjavila, Mercedes; (...); Carmona-Bayonas, Alberto

Article. 10.1007/s00259-023-06166-8. 2023


eLearning of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Megias-Vericat, JE

Meeting Abstract. 2018


Elotuzumab plus bortezomib and dexamethasone (EBd) versus bortezomib and dexamethasone (Bd) in patients (Pts) with relapsed/refractory multiple myeloma (RRMM)-2-year follow-up

Palumbo, A; (...); Jakubowiak, A

Article. 2016


Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia.

Peffault de Latour R; (...); Risitano AM

Article. 10.1056/NEJMoa2109965. 2022


ELTROMBOPAG ADDED TO STANDARD IMMUNOSUPPRESSION IMPROVES RESPONSE RATE IN SEVERE APLASTIC ANEMIA: RESULTS OF THE MULTICENTER PHASE III PROSPECTIVE RANDOMIZED RACE TRIAL

Risitano, A. M.; (...); de latour, R. Peffault

Meeting Abstract. 2021

  • Open Access.

ELTROMBOPAG ADDED TO STANDARD IST IS SUPERIOR TO IST ALONE AS FRONT-LINE TREATMENT FOR SEVERE APLASTIC ANEMIA: FINAL 2-YEAR ANALYSIS OF EBMT-SAAWP RACE STUDY

Risitano, Antonio Maria; (...); de Latour, Regis Peffault

Meeting Abstract. 2024


Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

González-López TJ; (...); González-Porras JR

Article. 10.1111/ejh.12725. 2016


Embracing critical thinking to enhance our practice

Marti-Bonmati, Luis

Editorial Material. 10.1186/s13244-023-01435-4. 2023


Emotional fMR auditory paradigm demonstrates normalization of limbic hyperactivity after cognitive behavior therapy for auditory hallucinations

Aguilar, EJ; (...); Turkington, D

Article. 10.1016/j.schres.2017.07.024. 2018


Empowering cancer research in Europe: the EUCAIM cancer imaging infrastructure

Marti-Bonmati, Luis; (...); EUCAIM Consortium European Soc Radiology, Hanna

Article. 10.1186/s13244-025-01913-x. 2025


Enhancing Cytogenetic Diagnostics: Incorporating Optical Genome Mapping in the Laboratory Routine

Diaz-Gonzalez, Alvaro; (...); Such, Esperanza

Meeting Abstract. 10.1182/blood-2023-180691. 2023


Epidemiology of Hereditary Thrombotic Thrombocytopenic Purpura (TTP) in Spain: Preliminary Results of a Study of the Spanish TTP Registry (REPTT)

Segui, Ines Gomez; (...); Garma, Julio Del Rio

Meeting Abstract. 2024


ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents

Neri E; (...); Bartolozzi C

Article. 10.1007/s00330-015-3900-3. 2016


Estudio de utilizacion de boceprevir y telaprevir para el tratamiento de la hepatitis C cronica.

Marrero-Álvarez P; (...); Poveda-Andrés JL

Abstract of Published Item. 10.7399/FH.2014.38.1.1128. 2014


European Perspective on Multiple Myeloma Treatment Strategies in 2014

Ludwig H; (...); Palumbo A

Article. 10.1634/theoncologist.2014-0042. 2014


EVALUATING REAL LIFE CRITERIA THAT COULD DRIVE PRICING & REIMBURSEMENT (P&R) APPROVAL OF ORPHAN DRUGS (ODS) IN SPAIN

Badia, F. J.; (...); Shepherd, J.

Meeting Abstract. 2019


Evaluation of 177Lu-DOTATATE treatment in patients with metastasic or unresectable paragangliomas and pheochromocytomas

Canon Sanchez, J.; (...); Utrera Costero, A.

Meeting Abstract. 2021


Evaluation of fibrosis and inflammation in diffuse liver diseases using intravoxel incoherent motion diffusion-weighted MR imaging

França M; (...); Miranda HP

Article. 10.1007/s00261-016-0899-0. 2017


Evaluation of minimal residual disease in relapsed/refractory multiple myeloma patients treated with venetoclax or placebo in combination with bortezomib and dexamethasone: BELLINI study analyses.

Moreau, P; (...); Kumar, S

Meeting Abstract. 2020


Evaluation of PET texture features with heterogeneous phantoms: complementarity and effect of motion and segmentation method

Carles, M; (...); Marti-Bonmati, L

Article. 10.1088/1361-6560/62/2/652. 2017


Evaluation of pneumatosis intestinalis as a complication of lung transplantation

Ripolles, V. Belloch; (...); Marti-Bonmati, Y. L.

Article. 10.1016/j.rx.2023.01.006. 2024


Evaluation of pneumatosis intestinalis as a complication of lung transplantation.

Belloch Ripollés V; (...); Martí-Bonmatí L

Article. 10.1016/j.rxeng.2023.01.013. 2024


Evidence levels in radiology: the insights into imaging approach.

Martí-Bonmatí L

Editorial Material. 10.1186/s13244-021-00995-7. 2021


Evolving Characteristics of Gadolinium-Based Contrast Agents for MR Imaging: A Systematic Review of the Importance of Relaxivity.

Kanal, Emanuel; (...); Marti-Bonmati, Luis

Article. 10.1002/jmri.29367. 2024


Executive dysfunction and cortical variations among intimate partner violence perpetrators and the association with sexism.

Romero-Martinez, Angel; (...); Moya-Albiol, Luis

Article. 10.1093/scan/nsae046. 2024


Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies.

Gudiol C; (...); de la Cámara R

Article. 10.1016/j.eimc.2019.01.013. 2020


Experience in the management of immunosuppressant treatment with hepatitis C virus protease inhibitors

Ruiz Ramos J; (...); Poveda Andrés JL

Article. 10.1016/j.gastrohep.2014.05.004. 2014


Experience of Home Delivery Program in Haemophilia Through an Association of Patients

Megias Vericat, J. E.; (...); Bonanad Boix, S.

Meeting Abstract. 2017


Experimental phantom evaluation to identify robust positron emission tomography (PET) radiomic features

Carles, Montserrat; (...); Mix, Michael

Article. 10.1186/s40658-021-00390-7. 2021


EXPERTS CONSENSUS ON THE FUTURE OF RARE DISEASES CARE AND ORPHAN DRUGS ACCESS IN SPAIN: A DELPHI STUDY

Paz S; (...); Urcelay J

Meeting Abstract. 10.1016/j.jval.2015.09.2016. 2015


Exploratory analysis for the implementation of antineoplastic logarithmic dose banding

Albert-Mari, A; (...); Poveda-Andres, JL

Article. 10.1007/s11096-018-0714-9. 2018


EXTENDED MULTICRITERIA DECISION ANALYSIS IN DIABETIC MACULAR EDEMA. MULTIDEX-EMD EXTENSION STUDY

F, de Andres-Nogales; (...); Martinez, M.

Meeting Abstract. 2019


F-18-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy

Carles, M; (...); Nicolay, NH

Article. 10.3390/cancers13143449. 2021


FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy.

Carles M; (...); Gkika E

Article. 10.3390/cancers13040814. 2021


FDG-PET/CT Focal Uptake on an Ocular Prosthesis

Repetto, A; (...); Bello, P

Editorial Material. 10.1097/RLU.0000000000002079. 2018


Feasibility and outcomes of transjugular intrahepatic portosystemic shunts in infants.

Martinez-Rodrigo, Jose J.; (...); Marti-Bonmati, Luis

Article. 10.1007/s00247-022-05575-5. 2022


Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease

Beltran, B; (...); Nos, P

Article. 10.1159/000492626. 2019


Femoral insertion site of the graft used to replace the medial patellofemoral ligament influences the ligament dynamic changes during knee flexion and the clinical outcome

Sanchis-Alfonso, V; (...); Marti-Bonmati, L

Article. 10.1007/s00167-015-3905-0. 2017


Femoral insertion site of the graft used to replace the medial patellofemoral ligament influences the ligament dynamic changes during knee flexion and the clinical outcome (vol 25, pg 2443, 2017)

Sanchis-Alfonso, V; (...); Marti-Bonmati, L

Correction. 10.1007/s00167-018-5271-1. 2019


Fetal exposure to tofacitinib during the first trimester: A healthy newborn case report

Fernandez-Sanchez, M; (...); Poveda-Andres, JL

Article. 10.1002/bdr2.1942. 2021


FINAL ANALYSIS OF GLOBAL SURVIVAL OF THE FIRST TEST IN PATIENTS WITH MULTIPLE NEW DIAGNOSTIC MYELOMA

Oriol, A.; (...); Benboubker, L.

Meeting Abstract. 2017

  • Open Access.

Final Analysis of the Phase 2 ELM-2 Study: Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL)

Ayyappan, Sabarish; (...); Prince, H. Miles

Meeting Abstract. 10.1182/blood-2023-179818. 2023


Findings and Utility of Chest Computed Tomography in Pediatric Tuberculosis

Moreno-Ballester, V; (...); Gomez-Pajares, F

Article. 10.1055/s-0037-1604418. 2018


Findings in sentinel lymph node biopsy in 19 patients with ovarian cancer

Utrera, A.; (...); Vera, V.

Meeting Abstract. 2019


Fostamatinib effectiveness and safety for immune thrombocytopenia in clinical practice.

Gonzalez-Lopez, Tomas Jose; (...); Garcia-Donas Gabaldon, Gloria

Article. 10.1182/blood.2024024250. 2024


Free automatic software for quality assurance of computed tomography calibration, edges and radiomics metrics reproducibility.

Saborido-Moral, Juan D.; (...); Carles, Montserrat

Article. 10.1016/j.ejmp.2023.103153. 2023


Frequency, characteristics and outcomes of Lymphoproliferative Disorders After Allogeneic Stem Cell Transplant: results of a multicenter study from the Grupo Espanol de Trasplante Hematopoyetico (GETH)

Garcia Cadenas, Irene; (...); Solano, Carlos

Meeting Abstract. 2018


Frequency, characteristics, and outcome of PTLD after allo-SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)

Garcia-Cadenas, I; (...); Spanish Grp Blood & Marrow Tran

Article. 10.1111/ejh.13226. 2019


Further psychometric validation of the GAH scale: Responsiveness and effect size

Cruz-Jentoft, AJ; (...); GAH Group

Article. 10.1016/j.jgo.2016.12.008. 2017


GAH SCALE PREDICTS TREATMENT TOLERABILITY IN OLDER PATIENTS (> 65 YEARS) DIAGNOSED WITH HEMATOLOGICAL MALIGNANCIES

Bonanad, S; (...); de la Rubia, J

Meeting Abstract. 2017

  • Open Access.

Ganglio centinela en cncer de prstata.

Martínez-Sarmiento M; (...); Boronat-Tormo F

Abstract of Published Item. 2019


Gastric Bleeding in Stem Cell Transplantation: A Focus on Gastric Vascular Ectasia Under Post-Transplant Cyclophosphamide, Sirolimus, and Mycophenolate Mofetil Prophylaxis.

Eirís J; (...); Sanz J

Article. 10.1016/j.jtct.2024.10.009. 2024


Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024


Genomic profiling of high-risk smoldering myeloma patients treated with a curative strategy: a biological study of the phase II GEM CESAR clinical trial

Medina, Alejandro; (...); Garcia-Sanz, Ramon

Meeting Abstract. 2023


Genotype and Allele Frequencies of Drug-Metabolizing Enzymes and Drug Transporter Genes Affecting Immunosuppressants in the Spanish White Population

Bosó V; (...); Aliño SF

Article. 10.1097/FTD.0b013e3182a94e65. 2014


Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study.

de la Rubia J; (...); Bonanad, Santiago

Article. 10.1016/j.jgo.2022.10.016. 2022


GERMINAL PREDISPOSITION IN PATIENTS WITH MYELOID NEOPLASMS: ASSOCIATION BETWEEN MOLECULAR DISORDERS AND CLINICAL HISTORY

Marta, Santiago; (...); Jose, Cervera

Meeting Abstract. 2021

  • Open Access.

GERMLINE PREDISPOSITION TO MYELOID MALIGNANCIES IN A CONSECUTIVE COHORT OF 183 PATIENTS

Santiago, M.; (...); Cervera-Zamora, J.

Meeting Abstract. 10.1016/j.leukres.2023.107247. 2023


Gray matter volume differences in intimate partner violence perpetrators and its role in explaining dropout and recidivism

Romero-Martinez, Angel; (...); Moya-Albiol, Luis

Article. 10.1016/j.jpsychires.2024.09.019. 2024


Guide to Good Humanization Practices in Patients with Rare Diseases. who vadis

Poveda Andres, Jose Luis

Editorial Material. 2022


GUIDELINES OF PRESCRIPTION IN FIRST LINE OF PATIENTS WITH MULTIPLE MYELOMA NOT CANDIDATES TO TRANSPLANTATION STRATIFIED BY AGE IN REAL LIFE IN SPAIN BETWEEN 2012 AND 2016

Cejalvo, M. J.; (...); Sarra, J.

Meeting Abstract. 2019

  • Open Access.

Haemodialysis significantly reduces serum levetiracetam levels inducing epileptic seizures: Case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12568. 2017


Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC)

López Rubio M; (...); Garcia-Marco JA

Article. 10.3109/10428194.2013.827187. 2014


Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: multicentric study

Valero-Garcia, S; (...); Spanish Hosp Pharmacy Units

Article. 10.7399/fh.10935. 2018


Hazardous drugs: new challenges, new opportunities.

Valero García S; (...); Poveda Andrés JL

Article. 10.7399/fh.2016.40.2.10462. 2016


Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study

Solana-Altabella, Antonio; (...); Martinez-Cuadron, David

Article. 10.3390/cancers14081921. 2022


Health-Related Quality of Life and Symptoms in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma Treated with Odronextamab Monotherapy in the Phase 2 ELM-2 Study

Iskierka-Jazdzewska, Elzbieta; (...); Ivanescu, Cristina

Meeting Abstract. 10.1182/blood-2023-180743. 2023


Hepatic and pancreatic fat as imaging biomarkers of metabolic syndrome.

Ballester-Vallés C; (...); Martí-Bonmatí L

Article. 10.1016/j.rx.2019.05.010. 2020


Hepatobiliary contrast agents for Liver Magnetic Resonance Imaging

Perez-Girbes, A., Lee, J. M., Marti-Bonmati, L.

Article. 10.1016/j.rx.2024.05.004. 2024


Hepatocarcinoma, our experience with radioembolization treatment

Olivan-Sasot, P; (...); Olivas-Arroyo, C

Meeting Abstract. 2018


High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis.

El-Qutob D; (...); Carrera-Hueso FJ

Article. 10.1016/j.hrtlng.2022.02.003. 2022


High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance

Garcia-Marco, JA; (...); GELLC Study Grp

Article. 10.3324/haematol.2018.204891. 2019


High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience

Rodriguez-Otero, Paula; (...); Gutierrez, Norma

Meeting Abstract. 2023


High-risk cytogenetic abnormalities in multiple myeloma: PETHEMA-GEM experience

Gonzalez-Calle, Veronica; (...); Gutierrez, Norma C.

Article. 10.1002/hem3.70031. 2024


Hospital pharmacy initiatives for improving the management of patients with congenital coagulopathies

Bruno Montoro-Ronsano, Jose; (...); Alberto Vella, Vincenzo

Article. 10.7399/fh.11729. 2022


Hospitalization budget impact during the COVID-19 pandemic in Spain.

Carrera-Hueso, F. J.; (...); Crespo-Palomo, C.

Article. 10.1186/s13561-021-00340-0. 2021


How can artificial intelligence optimize value-based contracting?

Poveda, Jose Luis; (...); Medrano, Ignacio H.

Letter. 10.1186/s40545-022-00475-3. 2022


How to integrate quantitative information into imaging reports for oncologic patients.

Marti-Bonmati, L; (...); Alberich-Bayarri, A

Article. 10.1016/j.rx.2018.02.005. 2018


How to Manage Patients with Lenalidomide-Refractory Multiple Myeloma

de Arriba de la Fuente, Felipe, Montes Gaisan, Carmen, de la Rubia Comos, Javier

Review. 10.3390/cancers15010155. 2023


Human AAT gene transfer to pig liver improved by using a perfusion isolated organ endovascular procedure

Sendra L; (...); Aliño SF

Article. 10.1007/s00330-015-3792-2. 2016


Hydrodynamic IL10 Gene Transfer in Human Colon: Results from an "EX VIVO" Study with Potential Clinical Application in Crohn's Disease

Frasson, M; (...); Aliño S

Article. 10.1097/MIB.0000000000001197. 2017


Hydrodynamic IL10 gene transfer in human colon: Results from an ex-vivo study with potential application in Crohn's disease

Sendra, L; (...); Alino, SF

Meeting Abstract. 2017


Hysterosalpingography and fertility: a technical relationship

Marti-Bonmati, L

Editorial Material. 10.1016/j.fertnstert.2018.06.034. 2018


I-131-MIBG treatment in patients with metastatic paraganglioma and pheocrhomocytoma

Bernal, J; (...); Bello, P

Meeting Abstract. 2020


IDENTIFICATION OF CANDIDATES FOR MASLD TREATMENT WITH INDETERMINATE VIBRATION- CONTROLLED TRANSIENT ELASTOGRAPHY

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2024


Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Article. 10.1016/j.cgh.2024.10.014. 2024


IDIOPATHIC UPPER GASTROINTESTINAL BLEEDING AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: AN UNPRECEDENTED COMPLICATION

Eiris, Juan; (...); Balaguer-Rosello, Aitana

Meeting Abstract. 2024


IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients.

Vallejo, Carlos; (...); Peman, Javier

Article. 10.3390/jof9060628. 2023


Imaging and CSF biomarkers for cognitive impairment

Agudelo, M.; (...); Bello-Arques, P.

Meeting Abstract. 2019


Imaging biomarkers and radiomics in pediatric oncology: a view from the PRIMAGE (PRedictive In silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers) project.

Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis

Article. 10.1007/s00247-023-05770-y. 2023


Imaging Biomarkers for the Diagnosis and Prognosis of Neurodegenerative Diseases. The Example of Amyotrophic Lateral Sclerosis

Mazon, M; (...); Marti-Bonmati, L

Review. 10.3389/fnins.2018.00784. 2018


Imaging Biomarkers in Amyotrophic Lateral Sclerosis

Cerda Alberich, Leonor; (...); Marti-Bonmati, Luis

Editorial Material. 10.1007/978-1-0716-1712-0_20. 2022


Imaging biomarkers in liver fibrosis.

Berzigotti, A; (...); Marti-Bonmati, L

Article. 10.1016/j.rx.2017.09.003. 2018


Imaging features and clinical data-based network analysis of CAR-T treated B- cell lymphoma patients in relation to their TP53 mutation status

Estepa-Fernandez, A.; (...); Alberich-Bayarri, A.

Meeting Abstract. 2024


Immune biomarkers of survival and infection-related mortality in multiple myeloma (MM) patients treated with lenalidomide and dexamethasone (Rd)

Maia, Catarina; (...); Paiva, Bruno

Meeting Abstract. 2022


Immune Biomarkers of Survival and Severe Infection in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with the Backbone Regimen Lenalidomide and Dexamethasone (Rd)

Maia, Catarina; (...); Paiva, Bruno

Meeting Abstract. 10.1182/blood-2022-163058. 2022


Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis

Paiva B; (...); Spanish Myeloma Group

Article. 10.1182/blood-2015-10-662320. 2016


IMMUNE THROMBOCYTOPENIA AND PREGNANCY: A SPANISH CASE SERIES OF 270 PREGNANCIES IN PRIMARY ITP.

Gonzalez-Lopez, TJ; (...); Porras, JRG

Meeting Abstract. 2017

  • Open Access.

Immune thrombotic thrombocytopenic purpura in older patients: Results from the Spanish TTP Registry (REPTT).

Gomez-Segui, I; (...); de la Rubia Comos, J

Article. 10.1111/bjh.19109. 2023


Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma

Perez, C; (...); Programa Estudio Terapeutica Hemop

Article. 10.1182/blood.2019004537. 2020


Immunoparesis recovery in newly diagnosed transplant ineligible multiple myeloma patients, an independent prognostic factor that complements minimal residual disease.

Lakhwani S; (...); Hernández MT

Article. 10.1007/s00277-024-06031-0. 2024


Immunoparesis Recovery in Transplant-Ineligible Newly Diagnosis Multiple Myeloma Patients: An Independent Prognosis Factor That Could Complement Prognostic Value of Minimal Residual Disease

Lakhwani, Sunil; (...); Hernandez, Miguel-Teodoro

Meeting Abstract. 10.1182/blood-2022-166826. 2022


Immunotherapy in multiple myeloma.

Asensi Cantó P, Arnao Herraiz M, de la Rubia Comos J

Article. 10.1016/j.medcli.2023.11.019. 2024


Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2016.1231405. 2017


Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart (R) in patients with multiple sclerosis

Edo Solsona MD; (...); Poveda Andrés JL

Article. 10.2147/PPA.S127508. 2017


IMPACT OF ADHERENCE ON SUBCUTANEOUS INTERFERON BETA-1A EFFECTIVENESS ADMINISTERED BY REBISMART (R) IN PATIENTS WITH MULTIPLE SCLEROSIS

Edo-Solsona, M.; (...); Poveda-Andres, J.

Meeting Abstract. 10.1016/j.jval.2016.09.512. 2016

  • Open Access.

Impact of an antimicrobial stewardship program on critical haematological patients.

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.7399/fh.2017.41.4.10709. 2017


Impact of combinations of single-nucleotide polymorphisms of anthracycline transporter genes upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1080/10428194.2020.1839650. 2020


Impact of motion and segmentation on PET texture features: evaluation with heterogeneous phantoms.

Carles, M; (...); Marti-Bonmati, L

Meeting Abstract. 10.1016/S0167-8140(17)32230-2. 2017


Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1038/tpj.2017.19. 2018


Impact of natural-killer immune reconstitution on the development of cytomegalovirus infection, non-relapse mortality, and graft versus host disease after allogeneic stem cell transplantation

Rodriguez-Veiga, R.; (...); Sanz, M. A.

Meeting Abstract. 2015


Impact of novel polymorphisms related to cytotoxicity of cytarabine in the induction treatment of acute myeloid leukemia

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1097/FPC.0000000000000286. 2017


IMPACT OF POSTTRANSPLANT CYCLOPHOSPHAMIDE ON TRANSFUSION REQUIREMENTS IN HLA MATCHED SIBLING PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.

Marco-Ayala, Javier; (...); Solves, Pilar

Article. 10.1016/j.jtct.2023.01.009. 2023


Impact of prior rituximab on outcomes of autologous stem-cell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: a multicentre retrospective Spanish group of lymphoma/autologous bone marrow transplant study

Redondo AM; (...); Martín A

Article. 10.1111/bjh.12676. 2014


Impact of Single Nucleotide Polymorphisms (SNPs) on Immunosuppressive Therapy in Lung Transplantation

Ruiz J; (...); Aliño SF

Article. 10.3390/ijms160920168. 2015


Impact of t(11;14) according to induction regimen in newly diagnosed transplant-eligible multiple myeloma patients: long term follow-up of GEM05MENOS65 and GEM2012 PETHEMA/GEM studies

Moreno, David; (...); Rosinol, Laura

Meeting Abstract. 2021


Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

Badia X; (...); Hernández C

Article. 10.1186/s13023-020-01507-4. 2020


Impact of Transporter Genes Polymorphisms in Standard Induction of Acute Myeloid Leukemia

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Meeting Abstract. 2015


Impact of voriconazole plasma concentrations on treatment response in critically ill patients

Ruiz, J; (...); Ramirez, P

Article. 10.1111/jcpt.12817. 2019


Impact on Outcomes of Human Leukocyte Antigen Matching by Allele-Level Typing in Adults with Acute Myeloid Leukemia Undergoing Umbilical Cord Blood Transplantation

Sanz J; (...); Sanz GF

Article. 10.1016/j.bbmt.2013.10.016. 2014


Implementation and results of a risk-sharing scheme for enzyme replacement therapy in lysosomal storage diseases

Edo-Solsona, MD, Vitoria-Minana, I, Poveda-Andres, JL

Article. 10.7399/fh.11262. 2020


Implication of Haemodiafiltration Flow Rate on Amikacin Pharmacokinetic Parameters in Critically Ill Patients

Ruiz-Ramos, J; (...); Ramirez, P

Article. 10.1159/000478969. 2018


Improved outcomes in allo-HCT for multiple myeloma patients with thiotepa-busulfan-fludarabine conditioning regimen and post-transplant cyclophosphamide, sirolimus and mycophenolate mofetil

de la Rubia, Javier; (...); Sanz, Miguel

Meeting Abstract. 2023


Improving the estimation of prognosis for glioblastoma patients by MR based hemodynamic tissue signatures

Fuster-Garcia, E; (...); Garcia-Gomez, JM

Article. 10.1002/nbm.4006. 2018


IN MEMORIAM To Julio Ponce, has works published, Doctor

Garrigues, V, Perpina, M, Marti-Bonmati, L

Biographical-Item. 10.1016/j.gastrohep.2019.02.001. 2019

  • Open Access.

INCIDENCE AND CHARACTERISTICS OF BACTERIAL INFECTIONS DURING THE THERAPY OF INDUCTION IN PATIENTS WITH MULTIPLE MYELOMA TREATED WITH NEW DRUGS. STUDY OF 67 PATIENTS FROM A SINGLE CENTRE

Martinez Garcia, M. F.; (...); Sanz Alonso, M. A.

Meeting Abstract. 2015

  • Open Access.

INCIDENCE AND CHARACTERISTICS OF POST-TRANSPLANT ALLOGENIC LYMPHOPROLIFERATIVE SYNDROMES. EXPERIENCE OF SPANISH GROUP OF HEMATOPOIETIC TRANSPLANT (GETH)

San Segundo, LY; (...); Solano, C.

Meeting Abstract. 2017

  • Open Access.

Incidence and Management of Aplastic Anemia in Spain (IMAS). An Ambispective Study of Biodonostia / Pethema

Vallejo, C; (...); Jarque, I

Meeting Abstract. 2020


Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.

Rodríguez-Veiga R; (...); Sanz GF

Article. 10.1007/s00277-019-03744-5. 2019


Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients with Newly Diagnosed Acute Myeloid Leukemia

Boluda, Blanca; (...); Montesinos, Pau

Article. 10.3390/cancers15082267. 2023


Incidence and risk factors of post-engraftment invasive fungal disease in adult allogeneic hematopoietic stem cell transplant recipients receiving oral azoles prophylaxis

Montesinos P; (...); Sanz MA

Article. 10.1038/bmt.2015.181. 2015


Incidence, Diagnosis, and Outcome of Acquired Thrombotic Thrombocytopenic Purpura (aTTP): A Nationwide Survey By the Spanish Apheresis Group

Izquierdo, Maria Cristina Pascual; (...); Salinas, Ramon

Meeting Abstract. 10.1182/blood-2019-123258. 2019


Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura

Pascual-Izquierdo, C; (...); Salinas, R

Article. 10.1002/jca.21894. 2021


Incidence, risk factors and therapy response of acute graft-versus-host disease after myeloablative hematopoietic stem cell transplantation with posttransplant cyclophosphamide.

Asensi Cantó P; (...); Sanz J

Article. 10.1038/s41409-024-02391-3. 2024


Incidence, risk factors, and outcomes of BK hemorrhagic cystitis in hematopoietic stem cell transplantation from HLA-matched and haploidentical donors with post-transplant cyclophosphamide.

Chorao, Pedro; (...); Sanz, Jaime

Article. 10.1016/j.jtct.2024.12.006. 2024


Incidence, risk factors, and thrombotic load of pulmonary embolism in patients hospitalized for COVID-19 infection.

García-Ortega A; (...); Martínez-García MÁ

Article. 10.1016/j.jinf.2021.01.003. 2021


Incompatibility of undiluted busulfan injection with a needle-free valve

Cueto-Sola, M; (...); Poveda-Andres, JL

Letter. 10.2146/ajhp140111. 2014


INCORPORATION OF DARATUMUMAB IN COMBINATION TO THE THERAPEUTIC PANORAMA OF PATIENTS WITH MULTIPLE MYELOMA IN RECAIDA: RESULTS OF HABITUAL CLINICAL PRACTICE IN SPAIN. GEMINI STUDY

Rios-Tamayo, R.; (...); Mateos Manteca, M., V

Meeting Abstract. 2019

  • Open Access.

Increased femoral anteversion in females with anterior knee pain relates to both the neck and the shaft of the femur.

Sanchis-Alfonso V; (...); Doménech-Fernández J

Article. 10.1007/s00402-023-05036-0. 2023


Increasing the Efficiency on Producing Radiology Reports for Breast Cancer Diagnosis by Means of Structured Reports

Damian Segrelles, J.; (...); Marti-Bonmati, L

Article. 10.3414/ME16-01-0091. 2017


Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images

Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis

Article. 10.3390/cancers15051622. 2023


Individualised dosimetry in patients with differentiated thyroid cancer based on external dose-rate. Optimisation of the number of measurements

Bautista-Ballesteros, JA; (...); Marti-Bonmati, L

Article. 10.1016/j.remn.2015.09.009. 2016


Individualization of prophylaxis with recombinant factor VIII in severe or moderate hemophilia A

Vericat, JEM; (...); Bonanad, S

Meeting Abstract. 2018


INDIVIDUALIZED DIAGNOSIS OF PSYCHOSIS BASED ON MACHINE LEARNING FROM FUNCTIONAL MAGNETIC RESONANCE DATA USING AN EMOTIONAL AUDITORY PARADIGM

Sanjuan, J; (...); Crespo-Facorro, B

Meeting Abstract. 10.1093/schbul/sbz020.615. 2019


Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Megias-Vericat, Juan Eduardo; (...); Bonanad, Santiago

Meeting Abstract. 10.1182/blood.V128.22.3802.3802. 2016


Infections of the Central Nervous System after Untelated Donor Umbilical Cord Blood Transplantation or Human teukocyte Antigen-Matched Sibling Transplantation

Balaguer Rosello A; (...); Sanz, J

Article. 10.1016/j.bbmt.2016.10.005. 2017


Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies

Megías-Vericat JE; (...); Aliño SF

Review. 10.1038/tpj.2014.80. 2015


Influence of Age on Treatment with Thrombopoietin Receptor Agonists in Patients with Immune Thrombocytopenia; A Retrospective Multicenter Study

Luisa Lozano, Maria; (...); Vicente Garcia, Vicente

Meeting Abstract. 10.1182/blood-2019-122237. 2019


Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy

Bastida, G; (...); Nos, P

Meeting Abstract. 10.1093/ecco-jcc/jjy222.581. 2019


Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

Megias-Vericat, JE; (...); Aliño SF

Article. 10.1080/10428194.2017.1323267. 2017


Influence of pharmacokinetic/pharmacodynamic ratio on vancomycin treatment response in paediatric patients with Staphylococcus aureus bacteremia.

Ruiz J; (...); Poveda JL

Article. 10.23736/S0026-4946.18.04978-2. 2018


Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia.

Megías-Vericat JE; (...); Montesinos P

Article. 10.1097/FPC.0000000000000431. 2021


Influence of Single Nucleotide Polymorphisms in Anthracycline Metabolism Pathway in Standard Induction of Acute Myeloid Leukemia

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Meeting Abstract. 2015


Insights into my experience as the Editor-in-Chief: a recap to close an unforgettable chapter.

Marti-Bonmati, Luis

Editorial Material. 10.1186/s13244-024-01878-3. 2024


Insulin resistance and NAFLD: Relationship with intrahepatic iron and serum TNF-alpha using 1H MR spectroscopy and MRI

Martin-Rodriguez, JL; (...); Gonzalez-Calvin, JL

Article. 10.1016/j.diabet.2019.01.005. 2019


Interdisciplinary recommendations document to improve adherence in patients with chronic inflammatory diseases: Adhing recommendations.

Bermejo San José F; (...); Sanromán-Álvarez L

Article. 10.7399/fh.2016.40.5.10180. 2016


Interventional solutions for post-surgical problems: a lymphatic leaks review

Gomez, Fernando M.; (...); Bonmati, Luis Marti

Review. 10.1186/s42155-024-00473-3. 2024


Interventional solutions for post-surgical problems: a lymphatic leaks review (vol 7, 61, 2024)

Gomez, Fernando M.; (...); Bonmati, Luis Marti

Correction. 10.1186/s42155-024-00483-1. 2024

  • Open Access.

Intraperitoneal vancomycin in neonates during peritoneal dialysis: A case report

Company-Albir, MJ; (...); Poveda, JL

Article. 10.1111/jcpt.12842. 2019


Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma

Blanes, M; (...); de la Rubia, J

Letter. 10.1007/s00277-019-03663-5. 2019


Intravenous Busulfan-Melphalan vs Melphalan as Preparative Regimen for Newly Diagnosed Multiple Myeloma: Long-Term Follow-Up of a Case-Control Study

Blanes, M; (...); de la Rubia, J

Meeting Abstract. 10.1016/j.clml.2019.09.473. 2019


Intravenous busulphan plus melphalan versus melphalan alone as conditioning regimen for newly diagnosed patients with multiple myeloma: Long-term follow-up of a matched case-controlled study

Blanes, M; (...); de la Rubia, J

Meeting Abstract. 2019


Intravenous SPION-labeled adipocyte-derived stem cells targeted to the brain by magnetic attraction in a rat stroke model: An ultrastructural insight into cell fate within the brain.

García-Belda P; (...); Gil-Perotín S

Article. 10.1016/j.nano.2021.102464. 2021


Intravitreal melphalan therapy for vitreous seeds in retinoblastoma: Implementation and outcomes of a new chemotherapy protocol.

Solana-Altabella A; (...); Poveda JL

Article. 10.1177/1078155220904410. 2020


Invasive mould disease in haematological patients

Ruiz-Camps, I, Jarque, I

Review. 10.1016/j.riam.2014.06.002. 2014


Invasive yeast infections in neutropenic patients

Camps, IR, Jarque, I

Review. 10.1016/j.riam.2015.11.001. 2016


Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19

Palanques-Pastor, T, Lopez-Briz, E, Andres, JLP

Article. 10.1136/ejhpharm-2020-002322. 2020


Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis.

Pozo-Rosich P; (...); Irimia P

Article. 10.1186/s10194-024-01747-w. 2024


Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma according to prior lines of treatment and refractory status: IKEMA subgroup analysis.

Hajek, Roman; (...); Dimopoulos, Meletios A.

Meeting Abstract. 10.1200/JCO.2021.39.15_suppl.8034. 2021


Isatuximab plus carfilzomib and dexamethasone in patients with relapsed multiple myeloma based on prior lines of treatment and refractory status: IKEMA subgroup analysis.

Dimopoulos, Meletios A.; (...); Hajek, Roman

Article. 10.1002/ajh.26602. 2022


Isavuconazole Pharmacokinetics in Critically Ill Patients: Relationship with Clinical Effectiveness and Patient Safety.

Martin-Cerezuela, Maria; (...); Ramirez Galleymore, Paula

Article. 10.3390/antibiotics13080706. 2024


Isolated and Dynamic Peripheral Blood Residual Disease Status Characterized By Mass Spectrometry Predicts Outcome in Patients with High Risk Smoldering Multiple Myeloma Treated in the GEM-CESAR Trial

Puig, Noemi; (...); Victoria Mateos, Maria

Meeting Abstract. 10.1182/blood-2023-182964. 2023

  • Open Access.

ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results

Ghobrial, Irene; (...); Mateos, Maria-Victoria

Meeting Abstract. 2021


Ixazomib Plus Lenalidomide/Dexamethasone (IRd) Versus Lenalidomide /Dexamethasone (Rd) Maintenance after Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma: Results of the Spanish GEM2014MAIN Trial

Rosinol, Laura; (...); Blade Creixenti, Joan

Meeting Abstract. 10.1182/blood-2021-146798. 2021


Knee Cartilage and Subchondral Bone Evaluations by Magnetic Resonance Imaging Correlate with Histological Biomarkers in an Osteoarthritis Rabbit Model

Sifre V; (...); Martí-Bonmatí L

Article. 10.1177/19476035221118166. 2022


La elastografia mediante tecnica Acoustic radiation force impulse es eficaz en la deteccion de fibrosis hepatica en el nino.

Aliaga, SDP; (...); Marti-Bonmati, L

Article. 10.1016/j.rx.2014.04.005. 2015


La heterogeneidad del flujo sanguineo en resonancia magnetica, biomarcador para clasificar por grados los astrocitomas cerebrales.

Revert Ventura AJ; (...); Gaspar C

Abstract of Published Item. 10.1016/j.rx.2012.01.011. 2014


Late Breaking Abstract - Incidence, risk factors and thrombotic load of pulmonary embolism in patients hospitalized with COVID-19

Bekki, Amina; (...); Angel Martinez-Garcia, Miguel

Meeting Abstract. 10.1183/13993003.congress-2021.OA2597. 2021


Lenalidomide and Dexamethasone in Transplant-Ineligible Patients with Myeloma

Benboubker L; (...); FIRST Trial Team

Article. 10.1056/NEJMoa1402551. 2014


Lenalidomide and dexamethasone maintenance with or without ixazomib, tailored by residual disease status in myeloma.

Rosinol, Laura; (...); Blade, Joan

Article. 10.1182/blood.2022019531. 2023


LENALIDOMIDE IN COMBINATION WITH R-ESHAP IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMAS (DLBCL) REFRACTORY OR IN RELAPSE: STUDY PHASE 2 OF THE GELTAMO SPANISH GROUP

Baile, M.; (...); Martin, A. A.

Meeting Abstract. 2017

  • Open Access.

Lenalidomide in combination with R-ESHAP in patients with relapsed or refractory diffuse large B-cell lymphoma: A phase 2 study from GELTAMO.

Martin Garcia-Sancho, A.; (...); Caballero, D.

Article. 10.1111/bjh.18989. 2023


Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma.

Mateos MV; (...); San Miguel JF

Article. 10.1056/NEJMoa1300439. 2013


Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial

Mateos, MV; (...); Miguel, JFS

Article. 10.1016/S1470-2045(16)30124-3. 2016


Less is more: Usefulness of the sentinel node technique in radical prostatectomy

Perez Ardavin, J.; (...); Vera-Donoso, C. D.

Meeting Abstract. 2022


Letter from the new Editor-in-Chief for Insights into Imaging.

Marti-Bonmati, L

Editorial Material. 10.1007/s13244-018-0617-2. 2018


Letter to the editor concerning "A new approach to corpus callosum anomalies in idiopathic scoliosis using diffusion tensor magnetic resonance imaging" by Joly O et al. (2014) Eur Spine J 23:2643-9

Domenech J; (...); Garcia-Marti G

Letter. 10.1007/s00586-016-4453-0. 2016


LIPID DROPLET MORPHOLOGY JUSTIFIES DISCORDANCES BETWEEN HEPATIC STEATOSIS GRADES AND MRI PROTON DENSITY FAT FRACTION

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2024


Long Term Discontinuation of Eltrombopag after Remission in Primary Immune Thrombocytopenia: 8-Year Follow-up Data from 15 Spanish Centers

Jose Gonzalez-Lopez, Tomas; (...); Sanz, Miguel A.

Meeting Abstract. 10.1182/blood-2019-129274. 2019


Longitudinal outcome over four decades of allogeneic stem cell transplantation: a single center experience.

Sanz, Miguel Angel; (...); Sanz, Jaime

Article. 10.1038/s41409-024-02319-x. 2024


Longitudinal studies of functional magnetic resonance imaging in first-episode psychosis: A systematic review

Gonzalez-Vivas, C; (...); Sanjuan, J

Review. 10.1016/j.eurpsy.2019.04.009. 2019


Los elementos decorativos ambientales en el Area de Imagen Medica mejoran la percepcion de agradabilidad del paciente.

Garcia Marcos R; (...); Diaz Dho R

Abstract of Published Item. 10.1016/j.rx.2012.07.006. 2014


Low activity treatment with I-131 in differentiated thyroid cancer

Olivan-Sasot, P; (...); Bello-Arques, P

Meeting Abstract. 2018


Lu-177-DOTATATE therapy in advanced pancreatic neuroendocrine tumors: data from 187 patients of the national registry SEPTRALU

Mitjavila-Casanovas, M.; (...); Jimenez-Fonseca, P.

Meeting Abstract. 2022


Lu-177-DOTATATE treatment in neuroendocrine tumours. A preliminary study

Hervas, I; (...); Yepes, AM

Article. 10.1016/j.remn.2016.10.003. 2017


Lu-177-DOTATATE Treatment In Unresectable Neuroendocrine Tumors: Our Experience

Agudelo, M; (...); Figueroa-Ardila, G

Meeting Abstract. 2018


Lutetium177 in patients with stage IV neuroendocrine tumours of any origin. Data from 321 patients of the multicenter national registry

Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.

Meeting Abstract. 2021


Lymphoscintigraphic findings in patients with lipedema

Olivan-Sasot, P; (...); Bello-Arques, P

Meeting Abstract. 2017


Machine Learning-Based Integration of Prognostic Magnetic Resonance Imaging Biomarkers for Myometrial Invasion Stratification in Endometrial Cancer

Rodriguez-Ortega, A; (...); Marti-Bonmati, L

Article. 10.1002/jmri.27625. 2021


Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use.

Marti-Aguado D; (...); Marti-Bonmati L

Article. 10.1007/s00261-020-02713-1. 2020


Magnetic resonance imaging structured reporting in infertility

Montoliu-Fornas, G, MARTÍ, L.

Article. 10.1016/j.fertnstert.2016.04.005. 2016


MAGNETIC RESONANCE IMAGING-BASED BIOMARKER ACCURATELY IDENTIFIES PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND CLINICALLY SIGNIFICANT LIVER FIBROSIS: A MULTICENTER, INTERNATIONAL, VALIDATION STUDY

Arnouk, Joud; (...); Marti-Bonmati, Luis

Meeting Abstract. 2021


Magnetic resonance imaging-based biomarker accurately identifies patients with nonalcoholic steatohepatitis and significant liver fibrosis: a multicentre, international, validation study

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2022


MAIC-10 brief quality checklist for publications using artificial intelligence and medical images.

Cerda-Alberich, Leonor; (...); Marti-Bonmati, Luis

Article. 10.1186/s13244-022-01355-9. 2023


Management of Adult Patients with Primary Immune Thrombocytopenia (ITP) in Clinical Practice: A Consensus Approach of the Spanish ITP Expert Group.

Mingot-Castellano ME; (...); González Porras JR

Article. 10.1155/2019/4621416. 2019


Management of chronic liver disease-associated severe thrombocytopenia in Spain: a view from the experts

Calleja-Panero, JL; (...); Gil, A

Article. 10.17235/reed.2020.6895/2020. 2020


Management of flexible cavovarus foot in patients with Charcot-Marie-Tooth disease: midterm results.

Megías-Vericat JE; (...); Poveda-Andrés JL

Article. 2021

  • Open Access.

Manipulación de fármacos para su administración por gastrostomía endoscópica percutánea en pacientes con esclerosis lateral amiotrófica y nutrición enteral.

Vázquez Polo A; (...); Vázquez Costa JF

Article. 10.20960/nh.03946. 2022


Mapping the scientific research on radiology departments: Global trends in publication, collaboration and trending topics

Cogollos, Lourdes Castello; (...); Marti-Bonmati, Luis

Article. 10.1016/j.ejrad.2021.109841. 2021


Mass spectrometry vs immunofixation for treatment monitoring in multiple myeloma.

Puig, Noemi; (...); Mateos, Maria-Victoria

Article. 10.1182/bloodadvances.2021006762. 2022


Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A

Bonanad, S; (...); Santos, S

Article. 10.1007/s12325-021-01853-0. 2021


Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple Myeloma.

Paiva B; (...); GEM (Grupo Español de Mieloma)

Article. 10.1200/JCO.19.01231. 2020


Medical imaging clinical trials unit: A professional need.

Penades-Blasco, Ana; (...); Marti-Bonmati, Luis

Article. 10.1016/j.ejrad.2021.110099. 2022


Meta-analysis and systematic review of the effect of the donor and recipient CYP3A5 6986A>G genotype on tacrolimus dose requirements in liver transplantation.

Rojas LE; (...); Aliño SF

Article. 10.1097/FPC.0b013e3283642fb3. 2013


Metabolic Phenotyping in Prostate Cancer Using Multi-Omics Approaches.

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Article. 10.3390/cancers14030596. 2022


Metaiodobenzylguanidine and Neuroblastoma

Balaguer, J; (...); Castel, V

Review. 10.1055/s-0036-1572362. 2015


METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII

Kocak, Burak; (...); Cuocolo, Renato

Article. 10.1186/s13244-023-01572-w. 2024


Metyrapone as treatment in the neonatal McCune-Albright syndrome

de Mingo, Carmen; (...); Garcia-Robles, Ana

Article. 10.1515/jpem-2020-0036. 2020


Microbiome preterm birth DREAM challenge: Crowdsourcing machine learning approaches to advance preterm birth research.

Golob JL; (...); Sirota M

Article. 10.1016/j.xcrm.2023.101350. 2024


MODELING OF IDH2 GENE MUTATIONS IN THE CAENORHABDITIS ELEGANS ORGANISM. DEVELOPMENT OF A NEW STUDY MODEL

Gonzalez-Romero, E.; (...); Cervera-Zamora, J.

Meeting Abstract. 2021

  • Open Access.

MOLECULAR APPROACH TO CHRONIC LYMPHOPROLIFERATIVE SYNDROMES IN THE DAILY CLINICAL PRACTICE OF A SINGLE CENTER

Mariam, Ibanez; (...); Irene, Luna

Meeting Abstract. 2021

  • Open Access.

MOLECULAR CHARACTERIZATION OF MULTIPLE MYELOMA PATIENTS BY USING A SINGLE ENRICHMENT PANEL IDENTIFYING SNVS, INDELS, CNVS AND TRANSLOCATIONS

Juan Manuel, Rosa-Rosa; (...); Joaquin, Martinez-Lopez

Meeting Abstract. 2021

  • Open Access.

Molecular Markers and Image Biomarkers. Importance in the Therapeutic Advance of Intraaxial Brain Tumors

Guajardo-Hernandez, U; (...); Zalazar, DR

Article. 2021


Monitoring Bottlenose Dolphin ( Tursiops truncatus) Welfare During a Functional Neuroimaging Study

Ames, Audra E.; (...); Tyack, Peter L.

Article. 10.1578/AM.50.6.2024.495. 2024


Monitoring coagulation factors during surgery. A systematic review

Eduardo Megias-Vericat, Juan; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11766. 2021


Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH).

Valero-García S; (...); Delgado-Sánchez O

Article. 10.7399/fh.11655. 2021


Monitoring the quality of the hospital pharmacoterapeutic process by sentinel patient program.

Fernandez-Megia, MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.10793. 2018


MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol

Loewe, C; (...); DDALIA Study Grp

Article. 10.2214/AJR.14.12604. 2015


MR Denoising Increases Radiomic Biomarker Precision and Reproducibility in Oncologic Imaging

Fernández Patón M; (...); Martí-Bonmatí L

Article. 10.1007/s10278-021-00512-8. 2021


MRI-PDFF captures the whole spectrum of lipid composition beyond traditional histological evaluation of macrosteatosis

Marti-Aguado, David; (...); Marti-Bonmati, Luis

Meeting Abstract. 2023


Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments

Gomez-Cebrian, N; (...); Pineda-Lucena, A

Review. 10.3390/cancers13184544. 2021


Multi-parametric MR Imaging Biomarkers Associated to Clinical Outcomes in Gliomas: A Systematic Review.

Oltra-Sastre M; (...); Garcia-Gomez JM

Article. 10.2174/1573405615666190109100503. 2019


N. VICTOR JIMENEZ TORRES (1942-2015) IN MEMORIAM

Climente Martí M, Poveda Andrés JL, Culebras J

Biographical-Item. 10.3305/nh.2015.32.4.9704. 2015


National Survey of the SEFH-2019: portfolio of services, healthcare activity, teaching and research in Hospital Pharmacy Services in Spain (vol 45, pg 32, 2021)

Perez-Encinas, Montserrat; (...); Angel Calleja-Hernandez, Miguel

Correction. 10.7399/fh.11740. 2021


National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Eduardo Megias, Juan; (...); Poveda Andres, Jose Luis

Meeting Abstract. 10.1182/blood-2022-169938. 2022


NEUROLOGIC COMPLICATIONS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH CALCINEURIN-FREE GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS

Balaguer Rosello, Aitana; (...); Sanz, Jaime

Meeting Abstract. 2023


New challenges of advanced therapies.

Megías-Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.farma.2023.11.008. 2024


NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial.

Rosa-Rosa, Juan Manuel; (...); Martinez-Lopez, Joaquin

Article. 10.3390/cancers14205169. 2022


Non-herniary space-occupying lesions of the abdominal wall: the radiologist's view

Marti-Bonmati, L, Ramirez-Fuentes, C, Cervera-Deval, J

Review. 10.1016/j.rehah.2015.06.005. 2015


Noninvasive Liver Assessment in Adult Patients With Fontan Circulation Using Acoustic Radiation Force Impulse Elastography and Hepatic Magnetic Resonance Imaging.

Buendia-Fuentes, F; (...); Martinez-Dolz, L

Article. 10.1177/2150135117732674. 2018


Objective Image Quality Comparison Between Brain-Dedicated PET and PET/CT Scanners.

Gandia-Ferrero MT; (...); Martí-Bonmatí L

Article. 10.1007/s10916-023-01984-7. 2023


Observational study to describe the impact of treatment combinations with Daratumumab versus other alternative regimens in patients with relapsed / refractory multiple myeloma. Spain real world evidence (RWE) data. GeminiS study

Tamayo, RR; (...); Mateos, MV

Meeting Abstract. 10.1016/j.clml.2019.09.245. 2019


Observational study to evaluate discontinuation of monotherapy with cobicistat-boosted darunavir in patients with human immunodeficiency virus

Solana-Altabella, Antonio; (...); Poveda-Andres, Jose Luis

Article. 10.1097/MD.0000000000032208. 2022


Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2

Kim, Won-Seog; (...); Walewski, Jan

Meeting Abstract. 10.1182/blood-2022-158406. 2022


ODs with a positive TPR conclusion, not subject to a conditional approval, and approved without requering a pass would be more likely to be reimbursed in Spain.

Poveda JL; (...); Badia X

Article. 10.1186/s13023-022-02610-4. 2023


Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial

Cabrero M; (...); Caballero D

Article. 10.1038/s41409-023-02171-5. 2024


Ofatumumab as Part of Reduced Intensity Conditioning in High Risk b-cell Lymphoma Patients: Results from a Prospective Multicenter Phase-II Trial

Cabrero, M; (...); Caballero, D

Meeting Abstract. 2020


Omics-Based Approaches for the Characterization of Pompe Disease Metabolic Phenotypes

Gomez-Cebrian, Nuria; (...); Puchades-Carrasco, Leonor

Review. 10.3390/biology12091159. 2023


Online course of pharmacokinetic monitoring in hemophilia with application in the clinical practice

Bonanad, S; (...); Poveda, JL

Meeting Abstract. 2018


Open-source AI-based networks for automatic segmentation of NSCLC on 3D and 4D PET/CT images

Radicioni, Gianluca; (...); Carles, Montserrat

Meeting Abstract. 2024


Optimisation of ultrasound liver perfusion through a digital reference object and analysis tool.

Alberich-Bayarri Á; (...); Martí-Bonmatí L

Article. 10.1186/s41747-019-0086-5. 2019


OPTIMIZING MANAGEMENT AND OUTCOMES OF ACTIVATED PHOSPHOINOSITIDE 3-KINASE DELTA SYNDROME (APDS) IN SPAIN: BEWAYAPDS PROJECT

Flores-Moreno, S.; (...); Gil, A.

Meeting Abstract. 2024


Optimizing the management of hereditary haemochromatosis: the value of MRI R2*quantification to predict and monitor body iron stores

Franca, M; (...); Porto, G

Letter. 10.1111/bjh.14982. 2018


Our experience in Sentinel lymph node biopsy after neoadjuvant chemotherapy treatment

Utrera, A; (...); Vera, V

Meeting Abstract. 2020


Overall survival prediction and risk stratification in patients with neuroblastoma through machine learning in the large multi-institutional PRIMAGE cohort.

Lozano-Montoya, Jose; (...); Alberich-Bayarri, Angel

Meeting Abstract. https://doi.org/10.1200/JCO.2024.42.16_suppl.10054. 2024


P-137: ITHACA, a randomized multicenter phase 3 study of Isatuximab in combination with Lenalidomide and Dexamethasone in high-risk smoldering Multiple Myeloma: safety run-in preliminary results (vol 21, pg S109, 2021)

Ghobrial, Irene M.; (...); Mateos, Maria-Victoria

Correction. 10.1016/j.clml.2022.03.011. 2022


Pan-Costochondritis Caused by Aspergillus Diagnosed by 18F-FDG PET/CT

Olivan-Sasot, P; (...); Bello-Arques, P

Editorial Material. 10.1097/RLU.0000000000002237. 2018


Pancreatic cancer, Radiomics and Artificial Intelligence: A Review.

Marti-Bonmati L; (...); Alberich-Bayarri A

Article. 10.1259/bjr.20220072. 2022


Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.

Marti-Aguado D; (...); Marti-Bonmati L

Article. 10.3389/fendo.2023.1213441. 2023


Panel Sequencing for Clinically Oriented Variant Screening and Copy Number Detection in Chronic Lymphocytic Leukemia Patients

Ibanez, Mariam; (...); Luna I

Article. 10.3390/diagnostics12040953. 2022


Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

San-Miguel, JF; (...); Richardson, PG

Article. 10.1016/S1470-2045(14)70440-1. 2014


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol

Garcia-Robles, Ana; (...); Carrascosa, MA

Article. 10.3389/fped.2020.00372. 2020


Paracetamol vs. Ibuprofen in Preterm Infants With Hemodynamically Significant Patent Ductus Arteriosus: A Non-inferiority Randomized Clinical Trial Protocol (vol 8, 372, 2020)

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Correction. 10.3389/fped.2021.834454. 2022


Paradoxical Findings in Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with C5 Inhibitors: Suboptimal Disease Control Perceived As Satisfactory

Gaya, Anna; (...); Vallejo, Carlos

Meeting Abstract. 10.1182/blood-2023-185939. 2023


Parasitic Infections in Hematopoietic Stem Cell Transplantation.

Jarque I, Salavert M, Pemán J

Article. 10.4084/MJHID.2016.035. 2016


Partial T Cell-Depleted Peripheral Blood Stem Cell Transplantation from HLA-Identical Sibling Donors for Patients with Severe Aplastic Anemia.

Sanz J; (...); Piñana JL

Article. 10.1016/j.bbmt.2019.08.020. 2020


Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project

Morillo-Verdugo, R; (...); Diaz-Olmo, J

Article. 10.7399/fh.11719. 2021


Patient and health practitioner perceptions about the role of hospital pharmacists along the care continuum: the Fharmaconectados Project.

Morillo-Verdugo R; (...); Díaz-Olmo J

Article. 2021

  • Open Access.

Patients with Advanced Neuroendocrine Tumors Treated with Peptide Receptor Radionuclide Therapy with 177Lu-DOTATE: Data from Spanish SEPTRALU Registry

Mitjavila, M; (...); Jimenez-Fonseca, P

Meeting Abstract. 2019


Peer review and authorship disclosure.

Marti-Bonmati, L

Editorial Material. 10.1016/j.rxeng.2023.05.004. 2023


Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE (177Lu) Is Effective and Safe in Patients with Pretreated Metastatic Neuroendocrine Tumors: Data from Spanish SEPTRALU Registry

Bello, P; (...); Mitjavila, M

Meeting Abstract. 2019


Peptide Receptor Radionuclide Therapy with [(177)Lu]Lu-DOTA-TATE in Patients with Advanced GEP NENS: Present and Future Directions.

del Olmo-Garcia, Maria I.; (...); Merino-Torres, Juan F.

Article. 10.3390/cancers14030584. 2022


Peptide receptor radionuclide therapy with [(177)Lu]Lu-DOTA-TATE.

Prado-Wohlwend S; (...); Endocrinology Working Group of the SEMNIM

Article. 10.1016/j.remnie.2021.11.001. 2022


Peptide receptor radionuclide therapy with [Lu-177]Lu-DOTA-TATE

Prado-Wohlwend, S.; (...); SEMNIM

Article. 2022


Pericardial synovial tumor, a rare entity to diagnose by imaging.

Utrera-Costero A; (...); Bernal-Vergara JC

Editorial Material. 10.1016/j.remn.2020.10.005. 2021


Pharmaceutical care to hospital outpatients during the COVID-19 pandemic. Telepharmacy

Margusino-Framiñán L; (...); Morillo-Verdugo R

Article. 10.7399/fh.11498. 2020


PHARMACOECONOMIC ANALYSIS OF THE USE OF VORICONAZOLE, POSACONAZOLE AND MICAFUNGIN IN THE PRIMARY PROPHYLAXIS OF INVASIVE FUNGAL INFECTIONS IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTS IN SPAIN

Grau S; (...); Rubio-Terrés C

Meeting Abstract. 10.1016/j.jval.2015.09.1944. 2015


Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Ballesta-Lopez, Octavio; (...); Poveda-Andres, Jose Luis

Article. 10.3390/ijms26041760. 2025

  • Open Access.

Pharmacogenetics of Metabolic Genes of Anthracyclines in Acute Myeloid Leukemia

Megias-Vericat, JE; (...); Montesinos, P

Review. 10.2174/1389200218666171101124931. 2018


Pharmacogenomics and the treatment of acute myeloid leukemia

Megías-Vericat JE; (...); Aliño SF

Review. 10.2217/pgs-2016-0055. 2016


Pharmacometabolomics by NMR in Oncology: A Systematic Review.

Gómez-Cebrián N; (...); Pineda-Lucena A

Article. 10.3390/ph14101015. 2021


Pharmacotherapeutic management of advanced therapy medicinal products

Luis Poveda-Andres, Jose; (...); Valero-Garcia, Silvia

Article. 10.7399/fh.13036. 2022


Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

Calleja Hernández MÁ; (...); Aragon, B

Article. 10.7399/fh.2017.41.1.10463. 2017


Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Robak, T; (...); Jolles, S

Article. 10.1182/bloodadvances.2020002003. 2020


Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial

Cabrero, M; (...); Caballero, D

Article. 10.1016/j.bbmt.2016.10.003. 2017


Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation

Vallejo C; (...); Jarque I

Article. 10.3324/haematol.2014.105908. 2014


Physical Activity In Haemophilia: Hemorrhagic Risk And Factor Levels (myPKFiT)

Querol-Fuentes, F; (...); Bonanad, S

Meeting Abstract. 2017


Pilot evaluation of home delivery programme in haemophilia

Megias-Vericat, JE; (...); Poveda-Andres, JL

Article. 10.1111/jcpt.12718. 2018


Pilot performance of a dedicated prostate PET suitable for diagnosis and biopsy guidance

Canizares, G; (...); Gonzalez, AJ

Article. 10.1186/s40658-020-00305-y. 2020


PK-GUIDED SWITCH BETWEEN STANDARD HALF-LIFE AND EXTENDED HALF-LIFE FACTOR VIII PRODUCTS

Vericat, JEM; (...); Iorio, A

Meeting Abstract. 2020


Portable magnetic resonance imaging of patients indoors, outdoors and at home.

Guallart-Naval, Teresa; (...); Alonso, Joseba

Article. 10.1038/s41598-022-17472-w. 2022


Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis

Megías-Vericat JE; (...); Aliño SF

Letter. 10.1038/tpj.2015.79. 2016


Post-transplant cyclophosphamide and sirolimus based graft-versus-host disease prophylaxis after allogeneic stem cell transplantation for acute myeloid leukemia.

Lazzari, Lorenzo; (...); Sanz, Jaime

Article. 10.1038/s41409-022-01725-3. 2022


Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.

Romero S; (...); Sanz J

Article. 10.1080/10428194.2018.1474462. 2019


Post-treatment changes of tumour perfusion parameters can help to predict survival in patients with high-grade astrocytoma

Sanz-Requena, R; (...); Marti-Bonmati, L

Article. 10.1007/s00330-016-4699-2. 2017


Practical guide to emergency treatment of thrombotic microangiopathy

Romero S; (...); Grupo de Microangiopatía Trombótica del Hospital Universitario y Politécnico La

Editorial Material. 10.1016/j.medcli.2018.01.013. 2018


Pre and post intervention study of antiblastic drugs contamination surface levels at a Pharmacy Department Compounding Area using a closed system drug transfer device and a decontamination process

Valero, S; (...); Poveda, JL

Article. 10.1016/j.yrtph.2018.03.001. 2018


Precise whole liver automatic segmentation and quantification of PDFF and R2*on MR images

Jimenez-Pastor A; (...); Marti-Bonmati L

Article. 10.1007/s00330-021-07838-5. 2021


Predicting survival, neurotoxicity and response in B-cell lymphoma patients treated with CAR-T therapy using an imaging features-based model

Ferrer-Lores, Blanca; (...); Alberich-Bayarri, Angel

Article. 10.1186/s13550-024-01172-9. 2024


Prediction of oncogene mutation status in non-small cell lung cancer leveraging radiomics from CT scans: A systematic review and meta-analysis with a special focus on artificial-intelligence-based methods

Fuster-Matanzo, Almudena; (...); Alberich-Bayarri, Angel

Meeting Abstract. 2024

  • Open Access.

Prediction of patient progression-free survival with 177Lu-DOTATATE in clinical practice: NEPTUNESEPTRALU model for patient selection

Mitjavila Casanovas, M.; (...); Carmona-Bayonas, A.

Meeting Abstract. 2024


Predictive Clinical Decision Support System Using Machine Learning and Imaging Biomarkers in Patients With Neurostimulation Therapy: A Pilot Study

De Andres, Jose; (...); Marti-Bonmati, Luis

Article. 2021

  • Open Access.

Predictive Clinical Decision Support System Using Machine Learning and Imaging Biomarkers in Patients With Neurostimulation Therapy: A Pilot Study.

De Andres J; (...); Marti-Bonmati L

Article. 2021


Predictive Factors for Thrombopoietin Receptor Agonist Free Responses in Chronic ITP Patients: A Multicenter Retrospective Study with Long-Term Follow-up

Luisa Lozano, Maria; (...); Vicente Garcia, Vicente

Meeting Abstract. 10.1182/blood-2019-125580. 2019


Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment

Minguela, Alfredo; (...); Periago, Adela

Article. 2021

  • Open Access.

Predictive value of 1q21 gain in multiple myeloma is strongly dependent on concurrent cytogenetic abnormalities and first-line treatment.

Minguela, Alfredo; (...); Periago, Adela

Article. 2021

  • Open Access.

Predictive value of texture analysis on lumbar MRI in patients with chronic low back pain.

Climent-Peris VJ; (...); Doménech-Fernández J

Article. 10.1007/s00586-023-07936-6. 2023


Predictors of severity in ischemic colitis: Usefulness of early ultrasonography

Pastor-Juan MDR; (...); Revert, R

Article. 10.1016/j.ejrad.2017.09.003. 2017


PREDICTORS OF TREATMENT FREE RESPONSES WITH THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH PTI

Lozano Almela, M. L.; (...); Vicente, V.

Meeting Abstract. 2019

  • Open Access.

PRELIMINAR STUDY OF THERAPY ADHERENCE CONTROLLED BY PRESCRIPTION OF MEDICATION AND SELF-PERCEPTION ADHERENCE OF INFLAMMATORY CHRONIC DISEASE PATIENTS

Garcia, EG; (...); Ivorra, JAR

Meeting Abstract. 10.1136/annrheumdis-2019-eular.5937. 2019


Preliminary results of activity-time curves analysis in PET/CT F-18-Choline in treated cerebral tumors

Olivan-Sasot, P; (...); Bello-Arques, P

Meeting Abstract. 2018


Preparación y administración de perfusiones de insulina en neonatología: Encuesta nacional.

García-Robles A; (...); Aguar-Carrascosa M

Letter. 10.1016/j.anpedi.2020.06.008. 2021


Preparation and administration of insulin infusions in neonatology: A national survey.

Garcia-Robles, Ana; (...); Aguar Carrascosa, Marta

Article. 10.1016/j.anpede.2020.06.015. 2021


Presence of acute and chronic renal failure in patients with paroxysmal nocturnal hemoglobinuria: results of a retrospective analysis from the Spanish PNH Registry

Villegas, A; (...); Urbano, A

Article. 10.1007/s00277-017-3059-x. 2017


Presence of good humanization practices in the healthcare of patients with rare diseases in Pharmacy Services

Company Albir MJ, Poveda Andrés JL, Edo Solsona MD

Article. 10.1016/j.farma.2023.06.0131130. 2024

  • Open Access.

Prevalence of burnout syndrome during the COVID-19 pandemic and associated factors

Oprisan, A.; (...); Marti-Bonmati, L.

Article. 10.1016/j.rx.2021.09.003. 2022


Prevalence of burnout syndrome in Spanish radiologists

Oprisan, A.; (...); Marti-Bonmati, L.

Article. 10.1016/j.rx.2021.09.001. 2023


Prevalence of burnout syndrome in Spanish radiologists.

Oprisan, A; (...); Marti-Bonmati, L

Article. 10.1016/j.rxeng.2021.09.013. 2023


Prevention and Management of Hormonal Crisis during Theragnosis with LU-DOTA-TATE in Neuroendocrine Tumors. A Systematic Review and Approach Proposal

del Olmo-Garcia, MI; (...); Merino-Torres, JF

Review. 10.3390/jcm9072203. 2020


PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers.

Martí-Bonmatí L; (...); Neri E

Article. 10.1186/s41747-020-00150-9. 2020


Primary and secondary immune thrombocytopenia (ITP): Time for a rethink.

Gonzalez-Lopez, Tomas Jose; (...); Fernandez-Fuertes, Fernando

Article. 10.1016/j.blre.2023.101112. 2023


Proactive therapeutic drug monitoring and pharmacogenetic analysis in inflammatory bowel disease: A systematic review

Ballesta-Lopez, Octavio; (...); Luis Poveda-Andres, Jose

Review. 10.7399/fh.11780. 2021


Probabilistic liver atlas construction

Dura E; (...); Goceri E

Article. 10.1186/s12938-016-0305-8. 2017


Prognostic factors in patients with advanced neuroendocrine neoplasia treated with radiopeptides (PRRT) - Data from the national registry SEPTRALU

Bello, P.; (...); Carmona-Bayonas, A.

Meeting Abstract. 2023


Prognostic factors in patients with advanced neuroendocrine tumors treated with 177Lu-DOTATATE

Casanovas, M. Mitjavila; (...); Jimenez-Fonseca, P.

Meeting Abstract. 2018


Prognostic Impact of Anthracycline Metabolism Gene Polymorphisms in Newly Diagnosed Acute Myeloid Leukemia Adults

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Article. 2014


Prognostic Impact of Cytarabine Pathway Gene Polymorphisms in Acute Myeloid Leukemia Adults Undergoing Induction Chemotherapy

Eduardo Megias, Juan; (...); Angel Sanz, Miguel

Article. 2014


PROGNOSTIC IMPACT OF TRANSPORTER GENE POLYMORPHISMS IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA ADULTS

Megias Vericat, J. E.; (...); Sanz, M. A.

Article. 2015

  • Open Access.

Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials

Arana P; (...); San Miguel JF

Article. 10.1038/leu.2017.320. 2018


Prognostic Value of Radiomics Signature By Diagnostic 18F-FDG PET/CT Analysis in Aggressive Non-Hodgkin's Lymphoma

Lores, BF; (...); Terol, MJ

Meeting Abstract. 10.1182/blood-2018-99-119851. 2018


Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma.

Tamariz-Amador, Luis-Esteban; (...); Troconiz, Inaki F.

Article. 10.1016/j.clml.2022.04.024. 2022


Progression-free survival at 2years post-autologous transplant: a surrogate end point for overall survival in follicular lymphoma

Jimenez-Ubieto, A; (...); GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) cooperative stu

Article. 10.1002/cam4.1217. 2017


Proposal of a short acquisition protocol for 18F-DOPA imaging in brain tumors:preliminary results

Orrego, N.; (...); Bello-Arques, P.

Meeting Abstract. 2024


PROPOSED MOLECULAR CLASSIFICATION OF ACUTE MYELOBLASTIC LEUKEMIA (AML) BASED ON SPLICING EVENTS

Liquori, A.; (...); Cervera Zamora, J.

Meeting Abstract. 2021

  • Open Access.

Prostaglandin Injection After Arterial Compromise Related to Hyaluronic Acid Filler

Megias-Vericat, JE; (...); Poveda, JL

Letter. 10.1097/DSS.0000000000001046. 2017


Prostate functional magnetic resonance image analysis using multivariate curve resolution methods

Prats-Montalban, JM; (...); Ferrer, A

Article. 10.1002/cem.2585. 2014


Proteometabolomics of initial and recurrent glioblastoma highlights an increased immune cell signature with altered lipid metabolism.

Cosenza-Contreras, Miguel; (...); Schilling, Oliver

Article. 10.1093/neuonc/noad208. 2023


PRRT of 200 patients from the SEPTRALU registry: real-world data

Casanovas, MM; (...); Jimenez-Fonseca, P

Meeting Abstract. 2020


Publishing in open access journals.

Quaia, Emilio; (...); Marti-Bonmati, Luis

Editorial Material. 10.1186/s13244-024-01794-6. 2024


Púrpura trombocitopénica trombótica inmune: sospecha y manejo básico en los servicios de urgencias. Revisión y consenso de un grupo de expertos de las sociedades científicas SEHH y SEMES.

Pascual-Izquierdo, Cristina; (...); de la Rubia Comos, Javier

Article. 10.55633/s3me/E099.2023. 2023


QUANTIFICATION OF CIRCULATING TUMOR CELLS IS THE MOST RELEVANT PROGNOSTIC FACTOR AT DIAGNOSIS IN PATIENTS WITH MULTIPLE MYELOMA, WHO ARE TRANSPLANT CANDIDATES, Abstracts

Juan-Jose, Garces; (...); Bruno, Paiva

Meeting Abstract. 2021

  • Open Access.

Quantification of H(2)(17)O by (1)H-MR imaging at 3 T: a feasibility study.

Martí-Bonmatí L; (...); Ferrer E

Article. 10.1186/s41747-021-00246-w. 2021


Quantification of Liver Iron Overload with MRI: Review and Guidelines from the ESGAR and SAR

Reeder, Scott B.; (...); Marti-Bonmati, Luis

Review. 10.1148/radiol.221856. 2023


Quantification of physical activity in adult patients with haemophilic arthropathy in prophylaxis treatment using a fitness tracker

Perez-Alenda, S; (...); Querol, F

Letter. 10.1111/hae.13388. 2018


Quantifying steatosis in the liver and pancreas with MRI in patients with chronic liver disease.

Vieira J; (...); França M

Article. 10.1016/j.rx.2019.11.007. 2020


QUANTITATIVE APPROACH TO ASSIST NEUROBLASTOMA ASSESSMENT BY MEASURING I-123 mIBG UPTAKE IN SCINTIGRAPHIC IMAGES

Martinez-Diaz, Rafael; (...); Peris-Fajarnes, Guillermo

Article. 10.5566/ias.1219. 2015


Quantitative evaluation of a non-CT based attenuation correction method for a new dedicated brain PET

Gandia-Ferrero, M.; (...); Marti-Bonmati, L.

Meeting Abstract. 2022


Quantitative Evaluation of Neonatal Brain Elasticity Using Shear Wave Elastography.

Garcés Iñigo E; (...); Martí-Bonmatí L

Article. 10.1002/jum.15464. 2020


Quantitative magnetic resonance imaging assessment of muscle composition in myotonic dystrophy mice

Bargiela, Ariadna; (...); Artero, Ruben

Article. 10.1038/s41598-023-27661-w. 2023


Quantitative structural analysis of trabecular alveolar bone in the mandible by multidetector computed tomography: differences according to tooth presence and type

Sanz-Requena, R; (...); Marti-Bonmati, L

Article. 10.1016/j.rx.2019.01.003. 2019


Radio theranostics in paragangliomas and pheochromocytomas

Wohlwend, S. Prado, Arques, P. Bello

Article. 10.1016/j.remn.2024.500017. 2024


Radio theranostics in paragangliomas and pheochromocytomas.

Wohlwend SP, Arques PB

Article. 10.1016/j.remnie.2024.500017. 2024


Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases.

Oliván-Sasot P; (...); Olivas-Arroyo C

Article. 10.1016/j.rx.2020.09.012. 2020


Radioembolization in patients with hepatocellular carcinoma: a series of 53 cases.

Olivan-Sasot, P; (...); Olivas-Arroyo, C

Article. 10.1016/j.rxeng.2021.03.001. 2023


Radiographic Location Does Not Ensure a Precise Anatomic Location of the Femoral Fixation Site in Medial Patellofemoral Ligament Reconstruction.

SANCHIS, L.; (...); Marti-Bonmati, L

Article. 10.1177/2325967117739252. 2017


Radiological, clinical, scintigraphic and serum markers response of advanced neuroendocrine tumors treated with 177Lu-DOTATATE

Mitjavila Casanovas, M.; (...); Jimenez-Fonseca, P.

Meeting Abstract. 2018


Radiologist income, receipts, and academic performance: an analysis of many nations

Semelka RC; (...); Elias J Jr

Article. 10.1177/0284185116633914. 2016


Radionuclide Therapy in the Continuum of Care of Neuroendocrine Tumors: Results of the SEPTRALU Study

Mitjavila, CM; (...); Jimenez-Fonseca, P

Meeting Abstract. 2020


Real world evaluation of teclistamab in patients with RRMM: results from the IMF immunotherapy database project

Costa, Luciano; (...); Wong, Sandy

Meeting Abstract. 2023


Real-life clinical practice in Spain in the setting of new drug availability for ITP treatment. A Delphi-based Spanish expert panel consensus.

Gonzalez-Lopez, Tomas Jose; (...); Jarque, Isidro

Article. 10.1080/09537104.2024.2336104. 2024


Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study).

Abrisqueta, Pau; (...); Villanueva, Miguel

Article. 10.1016/j.clml.2021.07.022. 2021


Real-world effectiveness of caplacizumab vs standard of care in immune thrombotic thrombocytopenic purpura.

Pascual Izquierdo, Maria Cristina; (...); Del Rio-Garma, Julio

Article. 10.1182/bloodadvances.2022008028. 2022


Real-World Experience in Extracorporeal photopheresisfor adults with graft-versus-host disease.

Asensi Cantó P; (...); Gómez-Seguí I

Article. 10.1016/j.jtct.2023.09.001. 2023


Recommendations for the Clinical Approach to Immune Thrombocytopenia: Spanish ITP Working Group (GEPTI).

Mingot-Castellano, Maria Eva; (...); Pascual-Izquierdo, Cristina

Article. 10.3390/jcm12206422. 2023


Recommendations for the diagnosis and treatment of patients with thrombotic thrombocytopenic purpura.

Mingot Castellano, Maria Eva; (...); Grp Espanol Aferesis GEA

Practice Guideline. 10.1016/j.medcli.2021.03.040. 2022


Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: update on laboratory tests for the study of monoclonal gammopathies.

Cardenas, Maria C.; (...); Cruz-Iglesias, Elena

Article. 10.1515/cclm-2023-0326. 2023


Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part II: methodological and clinical recommendations for the diagnosis and follow-up of monoclonal gammopathies

Cardenas, Maria C.; (...); Cruz-Iglesias, Elena

Article. 10.1515/cclm-2023-0325. 2023


Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis during Maintenance Is an Independent Prognostic Factor for Multiple Myeloma and Could Complement Prognosis Value of Minimal Residual Disease

Lakhwani, Sunil; (...); Hernandez, Miguel-Teodoro

Meeting Abstract. 10.1182/blood-2022-167247. 2022


Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection.

Lakhwani S; (...); Hernández MT

Article. 10.3324/haematol.2023.284154. 2024


REDEFINING OUTCOMES IN IMMUNE TTP: AN INTERNATIONAL WORKING GROUP CONSENSUS REPORT.

Cuker A; (...); Scully M

Article. 10.1182/blood.2020009150. 2021


Redox Status, Dose and Antioxidant Intake in Healthcare Workers Occupationally Exposed to Ionizing Radiation

Sebastia, N; (...); Rodrigo, R

Article. 10.3390/antiox9090778. 2020


Reduced incidence of neurologic complications after allogeneic hematopoietic stem cell transplantation with calcineurin-free graft-versus-host disease prophylaxis.

Balaguer-Rosello, Aitana; (...); Sanz, Jaime

Article. 10.1016/j.jtct.2023.07.008. 2023


Reduction in alert fatigue in an assisted electronic prescribing system, through the Lean Six Sigma methodology.

Cuéllar Monreal MJ; (...); Poveda Andrés JL

Article. 10.7399/fh.2017.41.1.10434. 2017


Re-evaluating the significance of the dive response during voluntary surface apneas in the bottlenose dolphin, Tursiops truncatus.

Fahlman, A; (...); Cauture, F

Article. 10.1038/s41598-019-45064-8. 2019


Relationship between neuroimaging and emotion recognition in Mild Cognitive Impairment patients.

Gandia-Ferrero, Maria Teresa; (...); Marti-Bonmati, Luis

Article. 10.1016/j.bbr.2023.114844. 2024


Relevancia de la anfotericina B liposomal en el tratamiento de las infecciones fúngicas invasoras en pacientes oncohematológicos.

García-Vidal C, Vázquez L, Jarque I

Article. 10.1016/j.riam.2021.03.001. 2021


Renal response to rescue treatments in Relapsed Refractory Multiple Myeloma (RRMM) patients with renal impairment: final data of a large, observational, prospective study (MIR50)

Garcia-Guinon, Antonio; (...); de la Rubia, Javier

Meeting Abstract. 2021


Reproducibility Analysis of Radiomic Features on T2-weighted MR Images after Processing and Segmentation Alterations in Neuroblastoma Tumors.

Veiga-Canuto, Diana; (...); Marti-Bonmati, Luis

Article. 10.1148/ryai.230208. 2024


Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review.

Prado-Wohlwend, Stefan; (...); Merino-Torres JF

Article. 10.3389/fendo.2022.957172. 2022


Results of the Ebmt Saawp Phase III Prospective Randomized Multicenter Race Study of Horse Atg and Ciclosporin with or Without Eltrombopag in Naive Saa Patients

de Latour, RP; (...); Risitano, A

Meeting Abstract. 2020


RESULTS OF THE PEGASUS PHASE III TRIAL FOR THE COMPARISON OF PEGCETACOPLAN WITH ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Jarque, Isidro; (...); Peffault, de latour Regis

Meeting Abstract. 2020

  • Open Access.

Retention of gadolinium compounds used in magnetic resonance imaging: a critical review and the recommendations of regulatory agencies.

Marti-Bonmati, L, Marti-Bonmati, E

Article. 10.1016/j.rx.2017.09.007. 2017


Retreatment PRRT with 177Lu-DOTATATE in patients with progressive neuroendocrine neoplasm: Spanish clinical experience from national registry

Mitjavila Casanovas, M.; (...); Hernando, J.

Meeting Abstract. 2024


RETROSPECTIVE CONTROL CASE STUDY ON THE EFFICACY OF AUTOLOGOUS TRANSPLANTATION OF HAEMATOPOIETIC PROGENITORS IN THE FIRST LINE TREATMENT OF PATIENTS WITH PERIPHERAL T CELL LYMPHOMA

Parra, ML; (...); Martin, A. A.

Meeting Abstract. 2017

  • Open Access.

Risk stratification in neuroblastoma patients through machine learning in the multicenter PRIMAGE cohort.

Lozano-Montoya, Jose; (...); Alberich-Bayarri, Angel

Article. 10.3389/fonc.2025.1528836. 2025


Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.

Abrisqueta P; (...); Bosch F

Article. 10.1182/blood-2013-05-502773. 2013


Role of imaging in the evaluation of vascular complications after liver transplantation.

Delgado-Moraleda JJ, Ballester-Vallés C, Marti-Bonmati L

Article. 10.1186/s13244-019-0759-x. 2019


Role of the nigrosome 1 absence as a biomarker in amyotrophic lateral sclerosis

Isabel Moreno-Gambin, Maria; (...); Vázquez-Costa JF

Article. 10.1007/s00415-021-10729-w. 2021


Rozanolixizumab, an Anti-FcRn Antibody: Final Results from a Phase II, Multiple-Dose Study in Patients with Primary Immune Thrombocytopenia

Robak, Tadeusz; (...); Jolles, Stephen

Meeting Abstract. 10.1182/blood-2019-129839. 2019


Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE).

García-Fernández FJ; (...); Moradi Kolbolandi M

Article. 10.1093/eurheartj/ehz067. 2019


Salvage therapy with topical posaconazole in lung transplant recipients with invasive Scedosporium infection.

Sole, A; (...); Peman, J

Article. 10.1111/ajt.14580. 2018


Same-day comparative protocol PET/CT-PET/MRI [68Ga]Ga-DOTA-TOC in paragangliomas and pheochromocytomas: an approach to personalized medicine.

Prado-Wohlwend, Stefan; (...); Merino-Torres, Juan Francisco

Article. 10.1186/s40644-023-00521-6. 2023


Secondary malignancies and survival outcomes after autologous stem cell transplantation for follicular lymphoma in the pre-rituximab and rituximab eras: a long-term follow-up analysis from the Spanish GELTAMO registry

Jimenez-Ubieto, A; (...); Lahuerta, JJ

Letter. 10.1038/s41409-018-0096-6. 2018


Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option

Roman, E; (...); Gorriz, JL

Review. 10.1016/j.nefro.2017.01.006. 2017


SEFH National Survey-2019: general characteristics, staffing, material resources and information systems in Spain's hospital pharmacy departments.

Pérez-Encinas M; (...); Calleja-Hernández MÁ

Article. 10.7399/fh.11565. 2020


Selective IgA Deficiency and Blood Component Transfusion: In Search of the Lost Evidence

Solves, Pilar; (...); de la Rubia, Javier

Article. 10.3390/hemato5020009. 2024


Selective ophthalmic intra-arterial melphalan therapy for advanced retinoblastoma: implementation and outcomes of a new chemotherapy protocol.

Valero García S; (...); Poveda Andrés JL

Article. 10.1177/1078155212457964. 2013


Selective sentinel node biopsy after intratumour administration of radiotracer in breast cancer patients treated with neoadjuvant chemotherapy in relation to the level of tumour response

Diaz-Exposito, R; (...); Caballero-Garate, A

Article. 10.1016/j.remn.2016.04.005. 2016


Sentinel lymph node biopsy in patients with locally advanced breast cancer with negative axilla after chemotherapy

Olivan Sasot, P.; (...); Sopena, P.

Article. 2015


Sentinel lymph node in apparent early ovarian cancer: open technique.

Lago V; (...); Domingo S

Article. 10.1136/ijgc-2019-000732. 2019


Sentinel lymph node technique in apparent early ovarian cancer: Laparoscopic technique.

Lago V; (...); Domingo S

Editorial Material. 10.1016/j.jmig.2019.09.790. 2020


SENTINEL LYMPH NODE TECHNIQUE IN EARLY STAGE OVARIAN CANCER (SENTOV): A PHASE II CLINICAL TRIAL

Lago, V.; (...); Domingo, S.

Meeting Abstract. 10.1136/ijgc-2019-ESGO.1284. 2019


Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial

Lago V; (...); Domingo S

Article. 10.1136/ijgc-2020-001289. 2020


SENTOV (SENTINEL LYMPH NODE TECHNIQUE IN OVARIAN CANCER): VIDEO TECHNIQUE

Lago, V.; (...); Domingo, S.

Meeting Abstract. 10.1136/ijgc-2019-ESGO.1302. 2019


SEPTRALU registry of 177-Lu-DOTATATE in neuroendocrine tumors: Data from 321 patients in clinical practice

Casanovas, MM; (...); Carmona-Bayonas, A

Meeting Abstract. 2021


SEQUENCING OF THE EXOME IN THE RECALLING OR REFRACTORY AML

Simarro Claudia, Sargas; (...); Eva, Barragan

Meeting Abstract. 2021

  • Open Access.

Sequential treatment of High-risk Neuroblastoma combining I-131 MIBG high-dose and Topotecan. First experience

Orrego, N.; (...); Bello-Arques, P.

Meeting Abstract. 2023


Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice

Aguas Peris M; (...); Nos, P

Article. 10.1097/MIB.0000000000001182. 2017


Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice

Aguas, M; (...); Nos, P

Meeting Abstract. 2017


Severity of Covid-19 Clinical Outcomes and Mortality in Multiple Myeloma Patients over Year 1 of the Pandemic

Martinez-Lopez, Joaquin; (...); San-Miguel, Jesus F.

Meeting Abstract. 10.1182/blood-2021-149192. 2021


Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons.

Seguí IG; (...); de la Rubia J

Article. 10.1080/17474086.2024.2318347. 2024


Significance of the impact of motion compensation on the variability of PET image features

Carles, M; (...); Marti-Bonmati, L

Article. 10.1088/1361-6560/aab180. 2018


SINGLE CELL-LEVEL CHARACTERIZATION OF THE IMMUNE MICROENVIRONMENT OF MULTIPLE MYELOMA IDENTIFIES CD27 NEGATIVE T LYMPHOCYTES AS TUMOR SPECIFIC

Perez, Cristina; (...); Paiva, Bruno

Meeting Abstract. 2020

  • Open Access.

Single Nucleotide Polymorphisms, SNPs, Associated With the Efficacy and Security of Immunosuppressive Treatment in Heart Transplantation

Sanchez-Lazaro, I.; (...); Salvador-Sanz, A.

Article. 10.1016/j.healun.2014.01.392. 2014


Single versus tandem autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma and high-risk cytogenetics: a retrospective study of the PETHEMA/Spanish Myeloma Group (GEM)

Villalba, Ana; (...); De la Rubia, Javier

Meeting Abstract. 2022


Single-Cell Characterization of Multiple Myeloma (MM) Immune Microenvironment Identifies CD27-negative T cells as Potential Tumor-Reactive Lymphocytes

Botta, C; (...); Paiva, B

Meeting Abstract. 10.1016/j.clml.2019.09.581. 2019


Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high risk smoldering multiple myeloma included in the GEM-CESAR trial.

Puig N; (...); Mateos MV

Article. 10.3324/haematol.2024.285742. 2024


SMPTall man lettering application in medication information systems as a quality and safety strategy in hospital organization

Iglesias Gomez, Ruben; (...); Poveda Andres, Jose Luis

Article. 10.1111/jcpt.13703. 2022


SNPs and taxane toxicity in breast cancer patients

Bosó V; (...); Aliño SF

Article. 10.2217/PGS.14.127. 2014


Sobre los riesgos asociados a las dosis de radiacion utilizadas en exploraciones practicadas en radiologia.

Candela-Juan, C, Marti-Bonmati, L

Letter. 10.1016/j.rx.2015.11.004. 2016


Somatostatin and Somatostatin Receptors: From Signaling to Clinical Applications in Neuroendocrine Neoplasms.

Del Olmo-Garcia MI; (...); Merino-Torres JF

Article. 10.3390/biomedicines9121810. 2021


Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients

Cantón R; (...); Solé A

Article. 10.1016/j.arbres.2014.09.021. 2015


Spanish consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria

Villegas A; (...); Urbano-Ispizua Á

Editorial Material. 10.1016/j.medcli.2015.12.012. 2016


Spanish National Registry of Celiac Disease: Incidence and Clinical Presentation

Cilleruelo ML; (...); Ribes-Koninckx C

Article. 10.1097/MPG.0000000000000446. 2014


Standardization analysis protocol proposal for isotopic ventriculography

Borrelli, P.; (...); Bello Arques, P.

Meeting Abstract. 2015


State-of-the-art of bone marrow imaging in multiple myeloma

Marti-Bonmati L; (...); Ruiz-Llorca C

Review. 10.1097/CCO.0000000000000230. 2015


Stress-Based Femur Fracture Risk Evaluation from Bone Densitometry

Nadal, E; (...); Marti-Bonmati, L

Proceedings Paper. 10.1007/978-3-319-68195-5_70. 2018


Study of the inferior colliculus in patients with schizophrenia by magnetic resonance spectroscopy

Martinez-Granados B; (...); Celda B

Article. 2014


Study on the Linezolid Prescription According to the Approval of Indication in a University Hospital

Pérez-Cebrián M; (...); Llopis-González A

Article. 2015


Studying Closed Hydrodynamic Models of "In Vivo" DNA Perfusion in Pig Liver for Gene Therapy Translation to Humans

Sendra L; (...); Aliño SF

Article. 10.1371/journal.pone.0163898. 2016


Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

González-López TJ; (...); González-Porras JR

Article. 10.1002/ajh.23900. 2015


Successful Second-Line Metronomic Temozolomide in Metastatic Paraganglioma: Case Reports and Review of the Literature.

Tena, I; (...); Pacak, K

Article. 10.1177/1179554918763367. 2018


Supervised Domain Adaptation for Automated Semantic Segmentation of the Atrial Cavity

Saiz-Vivo, Marta; (...); Naranjo, Valery

Article. 10.3390/e23070898. 2021


Survival of hematological patients after discharge from the intensive care unit: a prospective observational study.

Bernal T; (...); Albaiceta GM

Article. 10.1186/cc13172. 2013


Sustained Recovery of Uninvolved Heavy/Light Chain Pair Immunoparesis during Maintenance Discriminates Patients with Sustained Negative Minimal Residual Disease

Lakhwani, Sunil; (...); Teodoro Hernandez Garcia, Miguel

Meeting Abstract. 10.1182/blood-2023-179452. 2023


Syncope as a manifestation of mast cell activation disorder

Perales Chordá C; (...); Hernández Fernandez de Rojas D

Letter. 10.1016/j.anai.2014.11.019. 2015


Synergies Among Health Data Projects with Cancer Use Cases Based on Health Standards.

Gyrard, Amelie; (...); Alvarez, Eva Garcia

Article. 10.3233/SHTI240649. 2024


Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia

Megías-Vericat JE; (...); Montesinos P

Review. 10.3390/pharmaceutics14040878. 2022


T-cell Depleted Peripheral Blood versus Unmanipulated Bone Marrow in Matched Sibling Transplantation for Aplastic Anemia.

Chorao, Pedro; (...); Sanz, Jaime

Article. 10.1016/j.jtct.2023.01.016. 2023


The association of salivary caffeine levels with serum concentrations in premature infants with apnea of prematurity

Garcia-Robles, Ana; (...); Saenz Gonzalez, Pilar

Article. 10.1007/s00431-022-04628-z. 2022


The Brain Resting-State Functional Connectivity Underlying Violence Proneness: Is It a Reliable Marker for Neurocriminology? A Systematic Review

Romero-Martinez, A; (...); Moya-Albiol, L

Review. 10.3390/bs9010011. 2019


The contribution of brain volume to explain autonomous imbalance during recovery from acute stress in batterers.

Romero-Martinez, Angel; (...); Moya-Albiol, Luis

Letter. 10.1007/s00429-024-02772-w. 2024


The contribution of fenfluramine to the treatment of Dravet syndrome in Spain through Multi-Criteria Decision Analysis.

Gil-Nagel A; (...); Gil A

Article. 10.1016/j.yebeh.2022.108711. 2022


The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.

Medina-Herrera A; (...); Garcia-Sanz R

Article. 10.1038/s41408-024-01053-3. 2024


THE LASTING RESPONSE OF ELTROMBOPAG IN PRIMARY PTI IS A PREDICTOR FOR THE PROBABILITY OF DISCONTINUING THE SUCCESS OF ELTROMBOPAG

Porras, JRG; (...); Bastida, J. M.

Meeting Abstract. 2017

  • Open Access.

The radiology report: structure, style, and contents

Marti-Bonmati, L., Alberich-Bayarri, A., Torregrosa, A.

Article. 10.1016/j.rx.2022.01.013. 2022


The Role of ADAMTS13 Activity Levels on Disease Exacerbation or Relapse in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura: Post Hoc Analysis of the Phase 3 HERCULES and Post-HERCULES Studies

Strebel, Johanna A. Kremer Hovinga; (...); Scully, Marie

Meeting Abstract. 10.1182/blood-2022-156306. 2022


The Role of Imaging Studies in Favor of Possible Cerebellar Multiple System Atrophy: A Case Study.

Utrera-Costero, Ana; (...); Bello-Arques, Pilar

Article. 10.1097/RLU.0000000000003767. 2021


The role of intimate partner violence perpetrators' resting state functional connectivity in treatment compliance and recidivism.

Romero-Martinez, Angel; (...); Moya-Albiol, Luis

Article. 10.1038/s41598-024-52443-3. 2024


The sentinel node with technetium-99m for prostate cancer. A safe and, mature new gold standard?

Perez-Ardavin J; (...); Vera-Donoso CD

Article. 10.23736/S1824-4785.22.03416-1. 2022


The value of F-18-FDG PET/CT in two cases of Primary Pericardial Mesothelioma

Utrera-Costero, Ana; (...); Bello-Arques, Pilar

Article. 10.1007/s12350-021-02690-y. 2021


The value of the reflective discussion in decision-making using multi-criteria decision analysis (MCDA): an example of determining the value contribution of tabelecleucel for the treatment of the Epstein Barr virus-positive post-transplant lymphoproliferative disease (EBV+ PTLD).

Badia, Xavier; (...); Valles, Joan-Antoni

Article. 10.1186/s13023-024-03324-5. 2024


The view of experts on initiatives to be undertaken to promote equity in the access to orphan drugs and specialised care for rare diseases in Spain: A Delphi consensus

Torrent-Farnell, J; (...); Lizan, L

Article. 10.1016/j.healthpol.2018.03.002. 2018


The width of the third ventricle associates with cognition and behaviour in motor neuron disease

Vazquez-Costa, JF; (...); Sevilla, T

Article. 10.1111/ane.13022. 2019


Theranostic Contribution of Extracellular Matrix Metalloprotease Inducer-Paramagnetic Nanoparticles Against Acute Myocardial Infarction in a Pig Model of Coronary Ischemia-Reperfusion.

Ramirez-Carracedo, Rafael; (...); Zaragoza, Carlos

Article. 10.1161/CIRCIMAGING.121.013379. 2022


THROMBOTIC EVENTS IN PATIENTS WITH PTI TREATED WITH THROMBOPOIETIN RECEPTOR AGONISTS. IDENTIFICATION OF PREDISPOSING FACTORS

Lozano Almela, M. L.; (...); Vicente, V.

Meeting Abstract. 2019

  • Open Access.

Tissue hAAT gene expression but low secretion after pig liver hydrofection "in vivo"

Sendra, Luis; (...); Alino, Salvador F.

Article. 2014


Tissue iron quantification in chronic liver diseases using MRI shows a relationship between iron accumulation in liver, spleen, and bone marrow

Franca, M; (...); Pessegueiro Miranda, H.

Article. 10.1016/j.crad.2017.07.022. 2018


Topiramate pharmacokinetics in neonates undergoing therapeutic hypothermia and proposal of an optimised dosing schedule.

Marques MR; (...); Mangas-Sanjuan V

Article. 10.1111/apa.14944. 2020


Towards a symbiotic relationship between big data, artificial intelligence, and hospital pharmacy

Del Rio-Bermudez, C; (...); Poveda, JL

Editorial Material. 10.1186/s40545-020-00276-6. 2020


Toxic-metabolic encephalopathy induced by metronidazole and disulfiram: classics never die.

Chovi-Trull, Maria; (...); Poveda-Andres, Jose Luis

Article. 10.1136/ejhpharm-2024-004184. 2024


Trans-arterial chemoembolization with doxorubicin-eluting particles versus conventional trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A study of effectiveness, safety and costs.

Megías Vericat JE; (...); Poveda Andrés JL

Article. 10.1016/j.rx.2015.01.008. 2015


Transforming experimental radiology: Design and implementation of an innovative ePACS image storage system for AI imaging research environments.

Gomez-Rico Junquero, Ignacio; (...); Marti-Bonmati, Luis

Article. 10.1016/j.ijmedinf.2024.105549. 2024


Transfusion Burden in Allogeneic Hematopoietic Stem Cell Transplantation over Time: Experience from a Single Institution.

Solves, Pilar; (...); Sanz, Jaime

Article. 10.3390/jcm12103467. 2023


Transfusion of ABO non-identical platelets does not influence the clinical outcome of patients undergoing autologous haematopoietic stem cell transplantation

Solves P; (...); Sanz MA

Article. 10.2450/2015.0195-14. 2015


Translating radiological research into practice-from discovery to clinical impact

Smits, Marion; (...); Marti-Bonmati, Luis

Article. 10.1186/s13244-023-01596-2. 2024


Treatment adherence and other patient-reported outcomes as cost determinants in multiple sclerosis: a review of the literature

Lizan, L; (...); Polanco, C

Review. 10.2147/PPA.S67253. 2014


Treatment of invasive fungal disease using anidulafungin alone or in combination for hematologic patients with concomitant hepatic or renal impairment

Montesinos P; (...); Sanz MÁ

Article. 10.1016/j.riam.2014.10.003. 2015


Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma

Cejalvo, MJ; (...); de la Rubia, J

Article. 10.1007/s00277-021-04529-5. 2021


Ultrastaging protocol in sentinel lymph node for apparent early stage ovarian cancer.

Lago V; (...); Domingo S

Article. 10.1016/j.ygyno.2021.03.001. 2021


Undetectable levels of adalimumab in clinical practice: Should we say goodbye to the drug?

Bejar, S; (...); Mateu, PN

Meeting Abstract. 2020


Update of the Grupo Espanol de Leucemia Linfocitica Cronica clinical guidelines of the management of chronic lymphocytic leukemia

Garcia-Marco, JA; (...); Bosch, F

Editorial Material. 10.1016/j.medcli.2016.12.030. 2017


Update on iodine-refractory differentiated thyroid carcinoma

Casas, E. Abou Jokh; (...); Casas, J. A. Vallejo

Article. 10.1016/j.remn.2023.06.005. 2023


Update on iodine-refractory differentiated thyroid carcinoma.

Jokh Casas, E A; (...); Vallejo Casas, J A

Article. 10.1016/j.remnie.2023.07.003. 2023


Use and handling safety of Mini-Spike 2 (R) chemo and puresite for safe chemotherapy compounding in a hospital pharmacy

Garcia, SV; (...); Andres, JLP

Article. 10.1016/j.yrtph.2018.10.002. 2018


Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients

García-Robles AA; (...); Poveda JL

Letter. 10.1016/j.jns.2016.04.048. 2016


USE OF CAPLACIZUMAB IN THE ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Dominguez Hernandez, L.; (...); Gomez Segui, I

Meeting Abstract. 2019

  • Open Access.

Use of eltrombopag after romiplostim in primary immune thrombocytopenia

González-Porras JR; (...); González-López TJ

Article. 10.1111/bjh.13266. 2015


Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia.

González-López TJ; (...); García-Frade LJ

Article. 10.1111/ejh.13370. 2020


Use of Lu-177-dotatate in the treatment of iodine refractory thyroid carcinomas

Olivan-Sasot, P; (...); Bello-Arques, P

Article. 10.1016/j.remn.2016.08.001. 2017


Use of optical genome mapping in the cytogenetic diagnosis of multiple myeloma

de la Rubia, Javier; (...); Such, Esperanza

Meeting Abstract. 2023


Usefulness Of Post Treatment SPECT/CT In Whole Body Scan For The TNM Re-Staging In Patients With Well Differentiated Thyroid Cancer (WDTC)

Yepes Agudelo, A.; (...); Martinez Sanchis, B.

Meeting Abstract. 2019


Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data

Romero, R; (...); Nicolaides, KH

Review. 10.1002/uog.17397. 2017


Validation Of a Comprehensive Health Status Assessment Scale In Older Patients (>= 65 years) With Hematological Malignances. Gah Study

Bonanad, Santiago; (...); De La Rubia, Javier

Article. 10.1182/blood.V122.21.2979.2979. 2013


Validation of a multivariable prediction model for post-engraftment invasive fungal disease in 465 adult allogeneic hematopoietic stem cell transplant recipients

Rodriguez-Veiga, Rebeca; (...); Sanz, Miguel A.

Article. 10.1111/myc.12891. 2019


Validation of a risk score for post-engraftment invasive fungal disease in 414 adult allogeneic hematopoietic stem cell transplant recipients

Montesinos, P.; (...); Sanz, M. A.

Meeting Abstract. 2016


VALIDATION OF FREQUENT SPLICING EVENTS IN ACUTE MYELOID LEUKEMIA WITH POTENTIAL TO GENERATE NEOANTIGENS

Beatriz, Fernandez-Blanco; (...); Jose Vicente, Cervera Zamora

Meeting Abstract. 2021

  • Open Access.

Validation of the IMWG standard response criteria in the PETHEMA/GEM2012MENOS65 study: are these times of change?

Jimenez Ubieto, Ana; (...); Lahuerta, Juan-Jose

Article. 10.1182/blood.2021012319. 2021


VALUE CRITERIA FOR OUTCOMES BASED MANAGED ENTRY AGREEMENT OF CAR-T IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) THROUGH MCDA

Poveda, J. L.; (...); Lizan, L.

Meeting Abstract. 2023


Virtual conferences: results of an international survey on radiologist preferences and perspectives

D'Anna, Gennaro; (...); Ranschaert, Erik

Article. 10.1007/s00330-022-08903-3. 2022


VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Definitive Results of a Randomized Phase 3 Pethema/GEM Study

Dachs, LR; (...); Blade, J

Meeting Abstract. 10.1182/blood-2018-99-111924. 2018


WHAT ARE THE MAIN BRAIN CHANGES IN FMRI AFTER TREATMENT IN FIRST EPISODE PSYCHOSIS? A SYSTEMATIC REVIEW

Gonzalez, C; (...); Sanjuan, J

Meeting Abstract. 10.1093/schbul/sby017.676. 2018


What do biomarkers add: Mapping quantitative imaging biomarkers research.

Meseguer E; (...); Martí-Bonmatí L

Article. 10.1016/j.ejrad.2021.110052. 2022


WHOLE GENE SEQUENCING FOR THE IDENTIFICATION OF SPLICING MUTATIONS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML)

Mireya, Morote-Faubel; (...); Jose, Cervera

Meeting Abstract. 2021

  • Open Access.

Y-90 PET/MR imaging optimization with a Bayesian penalized likelihood reconstruction algorithm.

Calatayud-Jordan, Jose; (...); Torres-Espallardo, Irene

Article. 10.1007/s13246-024-01452-7. 2024


Zoledronic acid as compared with observation in multiple myeioma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial

Garcia-Sanz, R; (...); Mateos, MV

Article. 10.3324/haematol.2015.128439. 2015


Campos de estudio

Compartir